rfhg_151890.1

Basic information about the TSS

---

TSS ID: rfhg_151890.1 Species: human Chr: chr12		Start: 56117150 End: 56117173 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2563431,EH38E1615486)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000552314.1:-369 GeneID: 6171 HGNC/MGI_ID: HGNC:10354 UniProt_ID: Nearer transcript ids and distances: AF026844:-376 BC032611:-376 ENST00000546654.1:-382 BC066328:-472 BC082759:-500 view more...

Gene_name: ribosomal protein L41 Gene_symbol: RPL41 Gene_synonyms: L41 Gene_source: HGNC:10354

TATA-Box annotation

---

Distance to TSS:	528
Nearest PromoterID:	NM_021104
Entrez ID:	6171
Nearest Unigene:	Hs.112553
Nearest Refseq:	NM_021104
Nearest Ensembl:	ENSG00000229117
Gene Name:	ribosomal protein L41
Gene Alias:	L41
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.208333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL41 p2@RPL41 p3@RPL41 p4@RPL41 p5@RPL41 p6@RPL41 p7@RPL41
Sample		p1@RPL41	p2@RPL41	p3@RPL41	p4@RPL41	p5@RPL41	p6@RPL41	p7@RPL41
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	95.65	65.84	20.84	9.55	7.40	17.14	25.32
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	92.05	60.70	18.61	11.33	10.93	16.59	22.26
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	95.49	62.12	19.29	13.12	10.03	21.80	23.92
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	105.83	58.84	18.92	9.77	5.82	15.80	23.49
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	93.81	59.84	21.15	10.57	7.87	22.50	28.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	117.06	59.50	18.22	10.08	7.75	16.47	25.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	166.68	83.23	29.85	11.98	13.29	25.27	35.08
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	118.45	80.90	24.22	10.17	13.81	20.83	32.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	113.70	63.47	18.81	12.40	9.62	14.32	27.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	94.48	45.21	10.43	6.38	4.06	12.17	13.33
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	71.95	33.15	6.87	9.70	5.66	7.28	7.68
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	64.64	33.74	6.10	5.69	2.85	5.29	6.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	91.88	16.93	7.09	2.26	3.39	1.77	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	110.66	18.94	9.02	2.41	3.91	2.26	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	104.07	14.93	7.68	2.42	2.63	2.42	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	93.81	17.35	10.06	2.01	2.26	1.76	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	94.57	14.41	8.52	1.53	2.40	1.97	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	89.43	13.92	8.01	4.22	2.95	2.11	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	95.97	18.66	14.93	2.67	4.80	4.27	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	109.67	26.03	10.38	3.01	4.21	2.41	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	104.78	20.05	11.49	3.34	2.27	1.34	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	122.91	23.30	9.15	3.80	3.63	3.45	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	95.78	14.09	7.37	2.71	2.20	2.46	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	96.58	15.77	6.07	3.40	2.91	1.70	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	104.74	19.35	6.97	3.10	3.10	2.32	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	114.26	22.47	9.81	3.48	2.53	2.85	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	107.69	26.92	9.89	5.49	2.20	2.20	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	101.14	20.51	8.72	1.41	4.48	3.54	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	117.27	20.68	9.21	2.42	2.75	2.10	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	83.61	19.91	8.87	2.90	2.53	2.71	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	86.67	20.10	9.00	2.09	3.35	3.77	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	104.53	20.32	6.84	2.34	4.10	2.93	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	112.27	22.16	12.03	2.95	3.80	3.38	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	163.46	34.80	16.99	3.30	4.62	5.44	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	110.88	24.31	10.47	2.24	2.24	3.37	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	79.33	13.80	8.81	2.11	3.83	2.11	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	93.20	23.09	11.24	2.86	2.86	2.86	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	86.64	18.94	12.29	1.81	5.04	2.62	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	109.66	27.01	11.88	3.78	3.78	4.32	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	88.34	19.45	14.88	0.72	3.36	4.80	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	78.81	16.23	8.23	1.65	2.82	1.65	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	124.73	28.40	12.15	2.20	5.42	3.95	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	89.63	20.46	10.54	1.90	2.74	2.95	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	84.27	24.48	8.22	1.75	3.85	2.10	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	105.41	23.29	11.24	1.61	4.42	4.82	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	97.01	27.92	13.03	2.79	6.51	3.02	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	78.93	19.43	12.24	1.44	3.12	2.16	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	98.95	25.33	10.43	0.89	4.47	3.87	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	81.87	18.43	8.62	0.48	3.83	3.35	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	96.45	27.70	11.73	2.83	5.26	3.64	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	84.03	26.64	10.45	1.84	5.53	4.51	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	70.05	24.02	10.01	2.22	3.34	2.89	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	139.92	55.97	41.98	307.83	13.99	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	72.75	15.97	9.94	1.77	1.42	3.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	59.65	16.57	9.61	1.99	2.32	2.32	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	87.25	83.05	41.95	28.52	19.30	3.36	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	98.74	61.54	13.78	4.13	14.24	6.43	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	69.68	13.29	10.70	0.65	2.27	2.59	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	55.24	10.60	5.14	1.93	2.25	1.93	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	90.21	39.29	9.12	1.26	4.71	3.46	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	61.34	11.28	9.17	0.71	4.94	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	64.49	9.53	6.73	1.68	1.68	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	63.69	58.12	7.96	4.78	12.74	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	61.84	42.81	8.49	2.04	5.78	1.70	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	52.64	8.12	7.15	0.00	0.65	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	58.57	11.00	9.58	1.06	1.42	1.77	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	16.16	0.00	290.95	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	165.85	94.77	23.69	102.67	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	56.06	12.68	10.24	0.98	0.98	2.44	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	68.43	15.87	9.92	0.99	1.98	2.48	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	55.36	8.44	6.10	0.47	0.94	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	45.37	24.18	10.27	1.66	4.97	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	48.88	17.94	9.28	1.55	1.86	0.00	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	40.66	15.59	9.78	0.61	1.83	1.22	0.31
Adipocyte - breast, donor1	11376-118A8	30.25	11.72	6.18	2.69	3.33	1.90	0.48
Adipocyte - breast, donor2	11327-117E4	23.42	9.95	3.21	2.09	3.21	1.60	0.64
Adipocyte - omental, donor1	11473-119C6	30.41	10.31	4.71	1.53	1.91	1.15	0.38
Adipocyte - omental, donor2	11474-119C7	17.19	20.93	10.46	0.75	2.24	3.74	1.49
Adipocyte - omental, donor3	11475-119C8	17.08	12.73	5.36	2.01	0.67	0.33	1.67
Adipocyte - perirenal, donor1	11476-119C9	33.18	26.80	13.40	3.19	3.83	1.91	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	45.08	17.59	16.49	0.00	7.70	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.52	9.03	5.42	0.45	2.26	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	43.44	10.77	3.48	1.74	2.26	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	45.37	6.45	5.67	2.93	1.76	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	36.29	9.78	4.38	2.06	2.57	1.54	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	29.55	10.87	3.62	1.95	1.95	1.67	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	36.44	16.46	3.53	0.59	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	31.37	5.63	3.22	1.29	1.21	0.32	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	45.19	10.01	4.20	1.94	0.65	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	42.12	8.53	4.80	1.60	1.60	2.13	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	18.92	8.90	5.01	2.23	2.23	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	22.04	15.80	5.82	1.25	1.25	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	29.64	10.05	2.76	1.26	1.51	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	20.62	9.16	4.25	2.29	1.64	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	12.79	10.66	2.44	0.91	1.52	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	26.08	16.35	4.64	4.42	5.30	0.66	1.55
Alveolar Epithelial Cells, donor2	11590-120G6	12.91	16.49	4.30	2.15	4.30	0.36	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	17.97	4.79	4.79	2.40	5.99	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	21.41	9.18	4.50	2.88	1.62	0.72	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	15.06	8.37	0.00	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	27.12	11.09	5.75	2.67	2.47	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	28.95	22.43	19.34	0.57	4.92	0.92	0.34
Anulus Pulposus Cell, donor2	11463-119B5	22.29	25.23	21.31	0.24	4.41	1.22	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	53.92	28.31	14.83	1.35	7.64	5.39	3.15
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	49.93	27.35	10.85	1.30	6.08	4.34	3.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	77.05	32.10	6.42	2.14	2.14	12.84	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	50.22	27.20	13.75	1.20	5.98	3.89	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	53.12	31.62	16.44	3.79	10.12	5.06	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	50.83	27.06	9.90	1.98	6.60	4.62	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	42.24	30.86	9.75	2.60	6.17	4.87	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	41.75	28.64	13.59	0.49	10.19	3.40	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	59.98	30.88	7.72	1.78	5.34	3.56	4.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	44.07	39.17	17.70	2.26	6.40	3.39	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	53.70	29.75	10.16	2.90	7.26	2.18	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	62.69	30.09	11.28	2.51	3.76	1.25	6.27
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	38.05	16.64	8.07	2.14	5.11	3.13	1.65
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	51.86	35.48	8.19	2.73	4.09	6.82	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	55.94	26.99	13.87	1.21	4.07	3.47	2.11
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	57.33	31.61	7.50	1.07	10.18	3.75	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	51.20	33.06	12.47	2.08	5.86	4.16	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	60.67	30.20	10.69	3.47	4.81	4.54	3.74
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	45.85	21.46	8.78	0.98	3.90	6.83	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	46.44	27.70	10.62	3.65	5.14	3.32	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	79.25	40.82	9.61	4.80	9.61	3.60	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	21.24	7.08	3.54	3.54	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	44.43	19.38	9.95	2.74	5.15	3.60	2.06
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	50.34	29.36	8.39	0.00	8.39	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	52.91	33.01	11.65	3.88	5.34	4.37	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	57.68	35.67	12.90	1.90	6.45	1.90	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	37.55	30.28	9.69	0.00	3.63	3.63	7.27
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	47.31	38.76	19.95	0.57	6.27	6.27	5.13
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	38.91	24.80	11.12	1.50	5.34	2.14	2.35
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	57.30	25.55	9.81	3.10	3.36	2.58	2.06
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	45.51	33.78	12.67	0.94	5.16	5.63	3.28
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	46.62	25.08	7.72	2.25	1.61	2.89	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	73.49	37.10	12.13	2.85	6.42	3.57	4.99
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	41.53	25.74	13.45	0.58	4.68	4.09	2.92
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	49.07	29.51	12.04	1.51	5.42	2.71	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	49.90	28.51	22.57	4.75	2.38	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	63.06	36.62	12.71	2.03	6.61	4.58	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	68.77	37.18	13.50	1.78	5.35	4.84	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	67.35	29.23	11.44	0.64	3.18	5.08	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	49.63	33.23	11.65	0.86	6.04	6.04	3.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	53.13	28.58	13.97	2.33	6.77	2.96	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	54.23	26.10	13.63	2.03	5.51	3.48	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	44.40	34.01	10.39	2.83	3.78	2.83	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	46.11	22.72	8.82	0.85	4.24	3.90	1.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	55.59	30.11	6.95	0.00	2.32	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	54.93	29.58	14.79	4.23	4.23	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	39.45	25.30	9.65	1.72	4.07	2.79	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	82.43	37.30	9.02	1.20	9.63	4.21	4.81
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	59.05	41.55	15.31	4.37	5.10	5.83	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	56.55	28.97	16.32	2.30	5.29	3.45	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	56.11	30.60	2.55	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	52.88	30.00	11.19	2.29	6.86	4.58	3.31
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	41.08	23.53	11.35	2.27	5.99	4.54	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	59.36	20.50	11.93	4.59	4.59	4.28	3.37
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	52.10	32.98	11.95	5.26	8.13	2.87	4.30
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	42.80	25.50	10.42	2.22	3.77	1.55	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	57.98	22.89	7.63	1.53	4.58	3.05	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	54.28	31.02	12.74	3.88	6.09	3.32	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	47.13	23.83	7.68	2.38	5.56	2.12	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	61.79	27.26	8.72	3.27	2.91	3.63	2.91
Astrocyte - cerebellum, donor1	11500-119F6	21.62	22.11	12.53	6.02	4.30	2.33	1.47
Astrocyte - cerebellum, donor2	11580-120F5	19.68	35.43	12.84	3.42	6.16	1.71	0.86
Astrocyte - cerebellum, donor3	11661-122F5	38.80	17.20	4.61	2.94	2.94	0.21	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	43.22	24.75	12.20	6.27	4.88	2.79	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	72.80	38.83	18.44	4.37	8.09	3.24	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	44.30	20.88	13.42	3.13	5.67	3.58	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	114.80	37.73	16.63	9.98	10.90	4.93	3.10
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	115.89	46.23	23.18	10.52	9.40	9.40	4.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	108.79	40.85	21.05	8.31	9.67	8.53	4.55
Basophils, donor1	12241-129G9	33.21	9.15	5.49	12.29	3.66	0.52	0.52
Basophils, donor2	12242-129H1	55.92	14.79	6.49	9.02	4.69	0.72	0.36
Basophils, donor3	12243-129H2	42.63	4.26	5.59	7.94	1.91	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	8.84	7.76	2.37	1.94	1.72	0.22	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	9.14	12.34	1.37	0.91	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	21.52	14.35	0.00	7.17	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	37.03	40.17	17.57	1.88	10.67	4.39	4.39
Bronchial Epithelial Cell, donor5	11457-119A8	23.29	18.30	8.94	1.66	4.16	3.33	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	28.56	11.98	4.15	0.69	1.84	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	37.97	23.03	7.38	3.24	3.42	1.44	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	78.22	21.44	7.11	14.74	6.80	2.99	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	103.88	24.22	11.18	18.87	4.19	4.19	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	96.25	13.43	14.71	13.43	0.96	2.24	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	29.30	3.94	2.82	2.82	1.13	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	28.77	3.16	6.12	5.38	1.48	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	29.20	5.71	4.39	9.00	0.88	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	50.10	11.32	8.49	3.11	1.98	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	40.56	8.72	4.93	3.79	2.27	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	51.94	6.57	5.59	2.63	1.64	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	50.74	6.36	5.93	7.95	0.87	0.72	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	40.43	1.21	3.92	11.77	0.60	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	38.38	6.40	4.03	9.00	1.90	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	45.20	3.18	4.69	8.70	1.67	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	28.15	1.38	3.86	8.28	1.93	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	43.64	5.45	3.22	9.17	0.50	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	40.33	3.72	3.72	7.05	1.57	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	47.72	4.81	3.38	4.81	1.25	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	36.78	8.49	4.57	5.22	1.31	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	35.82	4.21	3.04	5.38	0.94	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	38.02	2.64	3.70	7.92	2.64	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	35.50	5.55	2.22	11.09	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	36.15	5.65	3.87	5.06	0.89	0.59	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	28.73	3.99	2.00	10.18	0.80	0.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	51.43	6.87	5.41	8.95	1.87	0.83	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	39.12	6.63	4.80	5.95	0.92	0.92	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	25.79	3.39	2.71	3.17	0.68	1.13	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	35.35	2.62	0.87	6.55	0.87	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	35.24	3.77	3.77	5.38	1.08	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	49.90	4.54	4.19	6.11	0.52	0.35	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	37.03	3.79	2.10	9.26	0.84	0.84	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	31.41	4.96	3.12	6.25	0.37	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	26.07	1.76	1.41	5.99	0.70	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	32.90	1.75	1.75	5.70	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	42.90	3.31	4.53	11.33	1.22	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	36.80	4.46	2.23	13.75	1.49	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	45.05	5.39	6.47	7.76	2.59	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.16	6.55	4.09	4.50	1.64	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	27.35	2.32	2.09	3.25	1.16	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	43.38	5.57	2.78	5.10	0.70	0.70	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	32.69	4.36	8.50	8.06	2.18	1.09	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	37.19	11.09	10.39	7.85	2.31	0.92	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	42.67	8.23	9.53	11.05	1.52	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	41.11	9.03	8.88	11.68	2.02	0.47	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	39.29	7.34	7.86	12.75	2.10	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	25.86	4.91	5.80	3.79	1.78	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	88.80	17.61	13.52	20.16	4.85	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	61.48	10.98	10.98	9.66	1.32	1.10	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	57.48	12.21	7.58	19.16	3.79	0.63	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	105.68	26.42	6.10	10.16	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	117.29	18.98	17.63	16.95	3.39	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	151.20	19.68	7.25	31.07	5.18	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	125.26	22.39	14.39	27.18	6.93	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	154.39	21.44	12.33	13.94	5.36	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	127.75	20.36	16.85	18.95	4.21	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	135.69	19.61	11.77	14.12	7.84	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	150.28	31.64	10.55	29.00	5.27	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	96.98	10.68	9.04	31.23	4.11	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	104.46	10.16	8.71	17.41	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	89.35	7.57	9.59	24.74	2.02	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	61.42	30.71	7.68	9.70	14.95	2.02	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	74.70	47.94	8.39	12.38	13.58	2.40	0.40
CD34+ Progenitors, donor1	11545-120B6	83.34	3.01	6.02	6.02	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	48.88	5.06	11.80	7.30	1.69	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	97.32	10.90	10.52	21.79	2.25	2.63	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	102.59	17.36	12.18	18.26	3.61	2.48	0.45
CD4+ T Cells, donor1	11225-116C1	81.77	6.07	4.28	28.56	2.86	1.43	0.36
CD4+ T Cells, donor2	11306-117C1	99.20	17.76	12.25	44.09	4.29	1.22	1.84
CD4+ T Cells, donor3	11382-118B5	96.07	9.45	12.20	34.46	3.66	1.52	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	49.26	9.19	9.44	7.91	2.04	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	76.59	9.43	6.29	12.58	1.80	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	82.21	8.91	7.76	9.20	4.60	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	138.91	24.18	17.54	23.23	4.27	2.37	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	191.03	25.99	20.37	46.35	11.94	1.40	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	141.74	26.37	23.07	42.85	16.48	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	45.09	13.30	9.83	7.51	3.03	1.45	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	96.09	16.27	12.20	10.00	2.20	1.36	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	85.44	18.86	9.51	13.22	5.00	1.45	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	82.04	14.35	17.93	36.31	6.72	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	81.76	19.57	14.32	28.65	8.73	1.05	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	57.20	11.44	9.68	16.72	2.20	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	38.37	6.32	8.01	6.32	2.95	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	95.99	15.58	12.05	7.90	2.29	1.45	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	90.55	18.04	15.70	9.36	5.35	1.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	115.57	10.06	12.51	44.60	2.45	1.63	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	132.38	15.54	17.69	42.88	4.29	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	121.94	16.14	14.35	43.04	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.44	9.83	12.05	9.46	2.23	0.93	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	51.77	7.36	8.45	6.07	2.17	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	53.17	9.04	9.46	7.15	2.31	0.21	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	127.41	17.19	24.77	26.29	7.08	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	151.64	21.23	22.96	40.73	3.90	1.30	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	97.62	8.28	12.20	28.76	3.49	2.18	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	135.59	34.15	23.75	15.84	8.41	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	106.17	35.08	20.31	15.69	6.46	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	192.62	41.87	19.54	19.54	6.98	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	65.36	17.45	13.85	13.02	2.49	1.11	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	64.78	19.39	14.72	12.27	4.42	0.74	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	103.18	32.34	12.32	12.32	13.86	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	116.75	26.14	16.83	12.53	7.16	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	106.64	44.32	13.85	12.46	15.23	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	75.30	12.44	13.10	20.30	4.91	1.31	0.65
CD8+ T Cells, donor2	11307-117C2	87.10	14.27	12.39	36.04	3.75	0.38	0.75
CD8+ T Cells, donor3	11383-118B6	105.79	14.90	12.88	33.58	4.54	1.26	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	49.55	42.21	22.94	9.41	5.05	8.72	3.67
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	53.92	40.02	19.65	6.95	7.19	9.35	5.51
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	66.48	57.45	22.16	9.85	9.58	10.94	5.20
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	56.14	60.34	30.32	9.61	8.11	12.61	6.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	47.28	38.16	18.96	8.64	6.48	7.44	3.60
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	47.75	34.11	18.19	7.05	5.00	9.55	3.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	60.62	67.36	23.25	7.39	7.82	17.82	7.39
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	63.17	55.54	23.69	7.90	7.11	15.00	5.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	55.35	56.52	19.00	7.74	6.80	19.00	6.80
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	68.83	70.34	25.06	7.25	9.06	19.02	5.74
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	67.11	64.20	27.89	6.39	7.26	18.30	8.42
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	59.15	58.88	25.31	6.39	7.73	18.65	8.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.90	17.51	11.38	7.44	2.63	3.94	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	44.18	14.57	9.11	4.55	3.19	3.19	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	33.56	12.68	8.95	8.95	6.71	2.24	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	45.38	28.09	16.57	7.92	3.96	7.20	3.60
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	48.05	36.54	16.98	8.34	3.45	6.62	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	43.84	34.18	17.68	4.71	5.66	6.13	4.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	53.56	50.70	15.85	5.07	8.87	12.04	6.02
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	55.36	47.36	17.84	9.84	8.30	9.84	5.84
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	42.96	42.96	19.88	5.77	7.37	9.30	8.98
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	56.99	48.57	23.71	7.27	7.27	13.39	5.35
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	49.66	43.75	20.10	5.12	4.73	14.98	6.70
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	61.27	38.58	16.64	10.59	5.29	9.83	6.81
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	53.80	13.65	12.85	20.07	4.01	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	65.75	17.49	4.90	17.49	1.40	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	54.09	15.03	5.01	18.03	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	45.69	9.14	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	31.62	26.19	7.41	1.48	5.43	2.47	0.99
Cardiac Myocyte, donor3	11686-122I3	49.56	11.15	5.68	0.53	4.00	2.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	19.41	12.13	7.97	6.24	2.08	2.77	0.69
Chondrocyte - de diff, donor2	11338-117F6	28.07	8.88	3.55	1.42	3.55	1.42	0.00
Chondrocyte - de diff, donor3	11410-118E6	39.94	13.54	5.92	2.39	2.62	0.57	0.11
Chondrocyte - re diff, donor2	11339-117F7	14.32	6.27	3.58	0.90	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	40.04	14.56	10.11	3.64	5.66	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	46.02	23.75	12.39	5.28	6.54	2.07	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	76.53	37.84	18.38	6.20	7.27	4.49	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	48.14	20.71	9.56	2.83	3.89	2.04	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	31.09	16.14	10.55	2.29	7.43	0.64	0.18
Corneal Epithelial Cells, donor1	11526-119I5	5.71	6.81	1.32	1.54	1.32	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	15.93	26.16	3.41	2.28	5.69	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	15.85	22.50	4.86	1.28	3.83	1.53	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	37.64	3.63	3.47	2.48	0.66	0.50	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	29.02	8.52	6.31	3.47	0.00	1.26	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	0.00	6.90	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	30.56	3.67	3.67	1.94	0.65	0.76	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	60.47	8.88	9.91	13.32	3.76	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	71.82	20.89	13.06	3.92	4.57	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	42.10	11.61	14.03	6.78	4.84	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	40.19	6.84	2.33	1.00	1.00	1.50	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	43.42	14.08	6.45	0.59	1.76	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	30.26	9.33	3.68	2.26	1.98	1.41	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	34.60	4.72	3.54	0.00	3.54	2.75	2.75
Endothelial Cells - Artery, donor1	11264-116G4	34.61	12.22	4.94	0.87	2.62	2.91	1.75
Endothelial Cells - Artery, donor2	11341-117F9	49.41	11.53	7.53	1.18	2.12	4.00	1.88
Endothelial Cells - Artery, donor3	11413-118E9	47.33	9.29	5.96	1.75	1.58	2.28	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.56	4.65	3.55	3.32	0.44	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	37.42	2.43	4.56	0.91	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	22.27	3.10	1.69	0.85	0.28	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	21.10	6.54	8.62	1.78	1.19	0.00	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	28.12	12.50	7.29	0.52	2.60	2.60	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	24.95	4.40	2.13	0.43	0.57	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	35.61	11.60	9.60	4.40	2.40	4.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	42.45	9.96	6.29	1.05	3.67	3.14	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.21	10.69	9.94	3.48	1.74	1.99	1.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	41.93	15.21	8.69	1.09	1.74	2.82	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	34.68	11.97	4.15	1.71	2.44	2.32	1.34
Endothelial Cells - Vein, donor1	11267-116G7	46.64	14.79	2.28	1.14	1.14	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	14.67	2.79	5.59	0.00	2.10	2.79	1.40
Endothelial Cells - Vein, donor3	11416-118F3	35.48	10.05	4.24	2.20	1.41	1.26	0.94
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	19.80	42.91	3.30	3.30	8.25	0.00	0.00
Eosinophils, donor3	12246-129H5	28.53	32.10	3.57	17.83	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	10.26	11.48	1.22	1.95	2.20	0.49	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	8.32	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.10	22.17	9.44	2.87	2.05	3.69	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	46.31	43.69	16.75	0.00	8.21	9.53	6.57
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	72.91	52.00	14.30	0.11	11.81	4.44	2.49
Fibroblast - Aortic Adventitial, donor1	11245-116E3	38.20	16.86	10.92	1.58	4.00	3.88	1.70
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.66	6.41	3.00	10.10	1.77	2.32	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	40.18	15.40	6.75	1.69	2.74	2.64	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	19.50	7.38	1.58	8.17	0.53	0.53	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	35.88	19.27	10.96	2.99	4.32	2.99	0.33
Fibroblast - Cardiac, donor1	11268-116G8	40.83	19.96	11.79	0.45	2.27	0.91	2.27
Fibroblast - Cardiac, donor2	11345-117G4	43.20	21.22	11.37	1.52	5.31	4.55	0.00
Fibroblast - Cardiac, donor3	11417-118F4	39.74	15.77	7.73	0.95	2.84	3.79	0.32
Fibroblast - Cardiac, donor4	11452-119A3	23.64	4.85	2.12	1.82	0.00	1.21	0.30
Fibroblast - Cardiac, donor5	11456-119A7	34.64	13.20	12.18	1.27	2.79	0.89	0.76
Fibroblast - Cardiac, donor6	11460-119B2	47.30	16.37	12.43	3.79	2.43	1.06	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.18	8.31	6.57	2.68	2.01	0.67	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	27.18	13.81	6.47	2.16	3.45	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	42.48	42.48	13.18	2.93	2.93	4.39	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	13.38	8.99	1.61	2.54	2.77	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	32.39	5.26	3.56	0.85	2.04	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	24.65	30.76	4.46	0.94	3.99	2.11	1.88
Fibroblast - Dermal, donor2	11346-117G5	17.45	30.66	6.13	2.83	5.66	2.36	2.36
Fibroblast - Dermal, donor3	11418-118F5	32.52	21.76	8.70	3.14	5.20	0.97	0.48
Fibroblast - Dermal, donor4	11450-119A1	40.13	33.91	12.55	4.07	4.07	1.58	1.36
Fibroblast - Dermal, donor5	11454-119A5	45.71	43.09	15.00	5.93	9.25	3.14	2.27
Fibroblast - Dermal, donor6	11458-119A9	41.42	46.62	18.19	7.31	10.56	3.41	2.11
Fibroblast - Gingival, donor1	11237-116D4	25.82	19.99	5.83	2.29	4.37	1.46	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	39.56	22.01	9.17	1.05	4.19	2.36	0.52
Fibroblast - Gingival, donor2	11318-117D4	53.50	36.11	10.94	8.30	6.33	2.64	1.05
Fibroblast - Gingival, donor3	11394-118C8	19.82	7.83	3.29	0.58	1.84	0.19	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	15.58	9.35	2.08	2.08	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	31.01	9.16	3.17	2.11	1.94	0.70	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	44.59	23.85	9.20	2.96	5.77	2.18	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	29.48	27.18	8.25	1.76	4.60	3.11	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.11	6.70	3.18	0.71	1.41	3.88	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	41.97	31.59	11.11	1.17	6.29	3.51	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	38.18	32.86	8.59	1.36	6.68	3.00	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	48.48	43.77	12.61	2.52	8.45	4.39	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	31.11	11.74	4.99	0.73	3.23	0.73	0.15
Fibroblast - Lung, donor1	11270-116H1	20.39	38.06	9.52	0.00	2.72	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	16.41	7.46	2.98	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	39.67	25.54	10.34	1.27	5.49	1.06	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	14.99	2.50	0.83	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	13.99	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.68	11.75	1.68	0.56	2.24	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	19.49	9.34	4.06	0.41	2.84	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	19.97	7.99	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	17.87	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	36.47	33.95	10.47	4.66	6.79	3.10	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	33.98	20.63	7.28	4.40	4.25	1.67	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.97	6.73	1.84	0.92	1.22	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.48	25.95	7.63	1.91	2.29	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	42.39	33.75	10.26	2.16	5.67	1.62	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.65	10.21	4.52	0.81	1.74	0.70	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	56.81	28.74	14.70	3.09	6.52	5.42	2.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	12.19	10.77	1.83	0.61	2.24	0.61	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.70	19.38	7.35	2.67	8.69	1.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	47.84	32.42	7.91	1.19	5.14	2.37	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	22.42	5.16	3.77	8.33	0.40	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	25.40	9.77	3.73	1.78	2.49	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.70	12.42	5.32	2.96	3.55	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.36	10.53	6.02	8.72	0.90	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	27.10	12.74	9.39	2.91	2.81	0.97	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	16.70	4.81	3.04	6.07	0.51	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	18.21	10.67	3.77	0.98	2.79	0.98	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	35.69	5.81	3.41	11.83	1.00	1.20	0.60
Fibroblast - skin normal, donor2	11561-120D4	25.72	15.87	9.14	2.81	3.72	1.81	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.99	4.53	4.53	5.14	0.60	0.91	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	43.41	7.46	5.63	1.91	1.66	0.91	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	40.17	8.72	6.15	3.93	1.71	0.17	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	15.44	5.58	2.96	8.54	1.31	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	24.29	18.85	13.10	2.88	4.69	1.38	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	21.25	21.09	4.89	3.04	3.88	1.86	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	68.53	104.91	19.60	0.47	21.80	6.27	1.88
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	421.04	199.44	0.00	88.64	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	13.94	10.46	6.10	0.87	6.97	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.32	14.91	5.55	1.56	1.39	3.64	1.73
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	30.19	7.03	3.64	2.60	1.30	1.30	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.85	12.78	5.37	1.02	1.28	1.79	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	108.71	84.21	39.04	16.08	10.72	12.25	6.89
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	148.67	128.89	59.98	19.78	15.95	23.61	7.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	149.76	112.68	58.48	44.22	13.69	16.83	9.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	109.20	117.47	28.95	10.75	14.89	3.03	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	92.47	55.71	31.28	17.81	11.64	4.34	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	85.59	59.84	34.08	23.78	5.15	10.90	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	102.56	87.23	30.40	13.22	10.84	2.11	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	110.56	49.25	31.31	14.35	6.52	6.52	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	80.48	107.90	38.47	33.17	13.71	15.48	6.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	52.29	47.91	25.58	8.20	7.07	7.35	2.69
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	36.70	33.00	15.15	3.82	4.43	3.45	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	52.11	38.41	22.83	8.60	4.84	9.40	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	42.50	18.83	9.42	4.83	3.59	2.23	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	37.79	28.65	12.46	3.18	4.15	2.35	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	67.90	41.47	17.48	8.34	6.30	6.10	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	57.73	15.06	9.36	7.76	1.60	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	46.84	16.07	8.22	3.74	2.24	1.12	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	50.49	20.33	8.31	3.06	2.62	1.75	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	69.73	20.39	13.89	6.80	3.84	2.36	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.87	20.82	13.03	3.34	2.86	1.27	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	54.29	20.33	8.04	4.02	1.79	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	54.04	19.56	12.50	5.85	3.02	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	47.84	18.32	15.27	2.88	3.90	1.70	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	45.75	15.61	8.69	4.61	1.68	1.95	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	63.47	11.03	8.22	3.85	2.19	1.56	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	41.67	9.56	8.54	2.22	1.54	0.85	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	47.36	14.50	11.40	2.32	2.32	1.88	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	48.09	14.64	9.07	6.07	2.33	2.16	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.69	13.48	12.05	6.53	3.47	2.45	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	72.83	18.15	11.55	5.36	2.89	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	42.77	13.37	10.72	3.00	1.38	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	46.03	20.85	11.84	3.84	1.33	2.00	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	61.50	12.78	8.60	3.09	1.54	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	59.65	20.42	13.04	1.97	3.07	0.98	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	53.33	19.13	13.45	5.51	3.89	3.40	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	63.18	20.53	7.38	4.49	2.57	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	43.02	14.88	10.71	1.80	2.37	0.95	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	53.46	17.72	10.91	3.16	3.64	1.58	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	73.29	16.72	10.03	2.74	2.43	1.22	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	44.01	16.20	11.29	3.14	2.93	1.78	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	60.82	16.03	8.34	4.39	2.85	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	61.16	18.24	7.86	3.37	1.68	1.68	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	29.16	11.30	9.54	1.30	2.04	2.04	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	56.15	20.86	12.30	3.48	3.21	5.35	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	47.28	14.38	11.17	2.45	1.84	2.45	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	36.92	16.45	12.44	2.20	2.33	2.46	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	42.83	18.70	11.39	1.90	4.88	0.54	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	49.04	11.06	10.32	3.87	0.92	1.29	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	64.26	10.53	7.68	3.07	3.07	1.75	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	5.95	2.98	0.00	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	36.54	10.95	6.46	3.43	1.45	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	45.40	9.28	7.67	2.02	0.81	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	30.75	4.57	7.88	0.25	0.00	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	43.00	35.43	39.61	11.15	4.18	8.16	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.52	40.37	25.73	8.17	6.16	5.39	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	45.42	49.71	35.19	7.57	5.73	8.59	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	122.98	60.08	43.81	19.71	5.01	10.64	5.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	105.96	52.84	35.60	12.71	8.48	11.87	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	45.20	74.25	26.29	10.15	11.07	12.91	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	133.64	59.40	42.07	7.42	9.90	12.37	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	121.84	56.86	37.13	15.47	8.12	16.63	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	157.24	68.99	57.76	28.88	9.63	14.44	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	86.94	45.21	12.17	10.43	3.48	10.43	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	113.27	58.91	24.41	10.09	4.88	6.84	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	86.89	52.30	25.94	13.59	7.82	8.24	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	93.30	59.98	26.66	19.99	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	107.38	45.30	20.13	9.23	5.03	7.55	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	89.88	41.51	15.03	7.52	4.90	6.21	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.95	26.84	15.10	9.23	3.36	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	88.42	41.35	15.90	13.04	6.36	2.23	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	92.39	42.46	23.10	8.15	7.13	3.74	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	141.99	68.91	29.23	10.44	6.26	6.26	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	109.96	62.42	23.48	6.87	3.44	1.72	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	92.94	40.25	16.58	4.14	2.66	3.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	137.23	42.35	30.49	11.86	1.69	10.16	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	100.24	45.98	26.10	12.84	4.14	6.21	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	98.73	38.89	22.09	7.13	5.29	5.52	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	121.18	68.49	26.34	10.54	0.00	31.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	104.18	32.29	20.37	12.69	5.00	4.61	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	104.64	37.49	14.67	5.87	4.56	3.26	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	137.11	42.14	23.41	1.34	3.34	4.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	116.74	45.85	18.11	6.93	5.78	1.54	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	83.87	31.50	13.69	12.67	5.82	2.40	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	91.94	54.67	17.39	4.97	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	119.85	55.21	20.76	7.55	3.30	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	108.03	38.02	14.48	9.66	6.03	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	128.69	45.27	20.35	6.61	8.14	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	134.81	44.27	24.33	10.37	6.38	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	144.55	52.79	21.21	9.87	5.92	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	153.46	102.70	28.33	25.97	9.44	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	142.94	42.01	19.25	14.59	9.34	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	84.70	49.59	18.87	7.46	3.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	76.29	43.23	18.65	10.17	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	109.83	33.43	29.85	14.92	4.78	4.18	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	66.48	34.94	23.29	3.40	7.76	2.91	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	36.52	33.10	1.14	0.00	3.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	36.18	14.14	6.65	2.08	6.24	2.91	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	60.72	29.24	6.75	0.00	4.50	3.37	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	41.23	18.40	4.76	2.54	3.81	1.59	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	66.42	39.69	11.28	1.25	7.94	4.18	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	41.43	35.39	17.17	5.45	6.85	6.61	2.55
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.59	29.20	10.30	5.57	6.08	6.41	3.71
Hep-2 cells mock treated, biol_rep3	11900-125F1	27.30	32.99	7.51	6.60	2.96	6.14	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	52.14	39.35	16.07	7.00	8.20	8.53	2.95
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.94	26.22	11.39	5.59	5.59	5.16	2.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	29.06	28.85	10.55	7.32	5.81	4.52	2.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	43.46	35.24	18.06	2.86	5.98	7.72	3.11
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	34.65	29.16	15.44	1.72	4.80	8.06	4.46
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	31.08	29.47	11.53	2.24	4.81	6.09	2.88
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.99	3.92	3.92	2.24	1.68	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	22.94	13.42	4.33	1.73	4.33	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	100.46	21.15	7.93	2.64	5.29	5.29	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.17	10.93	3.88	1.41	1.76	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	29.79	21.80	2.18	2.18	2.18	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	53.33	39.51	13.46	1.92	5.59	5.77	3.15
Hepatocyte, donor1	11523-119I2	29.05	30.27	4.84	3.63	6.05	0.00	0.00
Hepatocyte, donor2	11603-120I1	15.08	23.70	2.15	9.70	2.15	0.00	1.08
Hepatocyte, donor3	11684-122I1	39.88	22.70	4.29	5.52	4.91	0.61	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	39.81	18.93	20.89	24.15	2.61	8.48	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	39.33	6.99	5.77	5.94	1.05	1.75	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	38.97	18.93	6.59	2.47	3.16	2.20	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	63.68	19.10	0.00	3.18	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	53.40	13.35	0.00	20.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	27.08	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	45.68	62.30	15.23	2.77	11.08	4.15	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	42.55	12.51	0.00	17.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	59.34	47.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	51.26	5.13	2.56	10.25	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	68.56	9.14	0.00	27.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	60.10	37.36	12.99	4.87	16.24	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	45.02	41.68	6.67	3.33	18.34	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	36.31	7.26	0.00	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	29.12	48.97	13.23	2.65	14.56	2.65	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	41.02	51.00	16.63	3.33	11.09	1.11	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	89.05	5.24	0.00	15.71	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	45.98	56.06	22.68	0.63	16.38	1.89	5.67
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	43.31	72.69	13.92	0.00	15.47	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	35.53	49.74	14.86	0.00	18.09	1.94	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	43.47	11.27	1.61	16.10	4.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	59.74	0.00	0.00	35.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	43.19	44.82	15.48	0.00	13.04	3.26	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	29.81	31.91	10.50	1.26	9.24	4.20	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	100.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	38.58	54.65	16.88	1.61	21.70	4.02	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	27.70	48.93	4.62	3.69	12.00	1.85	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	30.16	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	36.82	44.84	13.69	0.47	17.47	2.83	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	44.44	52.60	11.79	0.91	9.07	1.81	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	29.48	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	30.13	48.43	19.37	2.15	17.22	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	49.55	49.55	21.60	3.81	16.52	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	82.15	16.43	0.00	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	25.51	41.45	12.12	2.55	14.03	1.91	4.46
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	49.21	52.86	16.40	0.00	10.94	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	39.27	34.28	16.42	3.57	7.85	5.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	69.68	6.64	3.32	19.91	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.01	45.68	13.89	3.40	10.80	3.40	2.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	59.70	7.02	1.76	3.51	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	69.15	6.29	0.00	6.29	3.14	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	28.51	45.20	12.52	2.09	15.99	5.56	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	39.84	33.20	15.49	2.21	13.28	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	42.15	6.48	3.24	9.73	3.24	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	35.75	26.16	20.05	1.74	8.72	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	47.25	15.75	0.00	18.00	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	38.33	6.97	0.00	13.94	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	43.74	20.27	1.07	13.87	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	47.11	20.78	8.31	1.39	8.31	1.39	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	34.20	5.70	0.00	14.25	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	30.37	39.58	18.41	1.84	6.44	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	48.41	9.08	0.00	18.15	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	37.25	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	32.78	30.66	12.69	0.00	11.63	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	20.40	10.20	4.81	1.71	1.63	3.26	1.63
Keratinocyte - epidermal, donor2	11349-117G8	8.78	9.96	1.76	0.59	0.00	3.51	0.00
Keratinocyte - epidermal, donor3	11421-118F8	27.54	17.13	6.06	4.07	2.84	2.56	1.14
Keratinocyte - oral, donor1	11251-116E9	32.24	19.53	9.76	4.09	4.65	2.50	0.11
Keratocytes, donor1	11527-119I6	16.50	9.63	1.38	1.72	2.06	0.34	0.00
Keratocytes, donor2	11607-120I5	21.09	36.33	4.69	2.34	12.89	0.00	1.17
Keratocytes, donor3	11688-122I5	44.46	14.42	3.36	0.99	2.57	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	74.73	6.59	10.99	15.39	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	46.39	22.65	6.47	3.24	9.71	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	32.87	7.50	5.54	1.96	2.42	0.69	0.12
Lens Epithelial Cells, donor3	11690-122I7	38.95	10.29	6.26	0.10	2.02	2.32	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	44.23	6.76	6.05	1.42	1.19	1.30	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	50.23	7.26	6.98	1.95	2.79	1.12	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	67.53	9.76	11.18	3.94	1.26	0.79	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	49.47	15.06	7.53	5.38	3.23	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	47.59	9.14	5.67	1.89	0.63	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	72.34	10.03	11.54	2.91	2.26	1.62	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	41.04	6.57	9.44	6.98	1.64	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	63.96	8.60	6.57	1.77	2.28	1.77	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	58.69	8.30	10.42	4.36	1.97	0.99	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	62.89	10.68	4.75	4.75	1.98	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	58.55	8.14	5.62	3.49	1.55	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	57.03	9.26	10.74	1.85	2.41	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	46.34	10.45	6.97	3.83	2.44	1.39	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	59.15	8.35	6.92	3.58	2.39	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	64.97	11.95	8.52	2.88	1.51	0.96	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	52.35	10.16	8.93	2.46	1.85	2.77	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	67.34	8.42	6.23	2.81	1.25	2.18	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	63.31	9.88	9.15	1.83	1.83	1.83	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	48.38	7.90	8.23	3.95	0.99	1.65	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	71.75	9.66	5.27	3.51	1.76	1.46	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	75.92	11.20	12.70	1.99	2.74	1.74	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	58.20	12.12	9.21	2.42	1.94	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	65.71	9.96	9.69	3.23	3.50	2.96	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	66.00	11.20	9.39	3.94	1.97	2.27	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	68.43	15.55	8.29	3.11	3.63	1.04	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	51.72	8.59	6.49	4.19	1.05	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	61.95	9.17	8.42	1.80	1.65	1.05	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	57.09	13.76	12.38	5.50	4.82	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	65.29	7.15	7.15	4.14	2.45	2.82	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	59.59	9.01	11.24	2.12	1.70	1.48	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	45.55	11.15	4.85	3.39	2.91	2.42	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	58.88	6.95	6.62	1.98	2.98	0.99	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	57.73	8.92	7.81	2.85	1.36	1.12	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	54.42	10.37	8.89	6.66	1.11	1.85	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	57.82	8.65	6.67	4.94	2.47	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	51.84	8.52	8.52	2.06	2.06	1.37	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	58.86	9.97	5.47	4.50	1.29	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	59.95	4.26	6.39	5.17	1.22	1.22	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	60.05	8.68	7.98	2.94	1.40	2.10	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	51.20	9.60	7.11	1.42	2.49	2.13	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	54.78	11.63	6.30	4.85	3.39	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	70.18	7.78	7.94	0.93	3.73	1.56	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	71.62	11.82	7.88	1.79	1.79	2.51	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	51.29	7.51	5.23	5.23	1.31	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	83.58	12.01	14.83	4.94	2.35	1.41	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	46.78	5.94	8.29	1.36	1.61	0.87	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	57.88	7.68	4.35	0.77	0.51	0.77	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	49.23	11.04	8.65	1.19	3.28	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	149.56	9.06	9.06	0.00	4.53	2.27	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	141.15	28.38	15.34	3.07	3.84	6.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	95.01	8.91	11.88	2.23	2.23	5.20	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	196.75	21.58	21.16	15.23	5.08	8.89	5.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	115.35	11.25	16.88	9.14	0.70	5.63	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	136.36	14.94	17.75	6.54	1.87	5.60	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	178.80	21.13	13.91	12.37	2.58	6.70	4.12
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	176.04	14.27	13.08	13.08	1.19	5.95	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	152.45	13.80	11.99	5.20	1.58	3.39	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	178.57	18.61	22.98	11.34	2.62	9.89	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	174.22	19.36	23.41	8.10	2.70	6.30	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	147.00	8.94	15.31	6.50	1.76	3.79	1.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	174.60	19.00	15.41	6.68	2.57	3.08	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	146.79	17.64	14.11	3.88	1.41	6.35	2.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	75.96	14.66	10.66	4.66	0.00	6.00	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	182.87	14.26	12.23	13.75	1.53	5.60	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	167.82	19.48	17.08	6.40	1.87	5.34	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	256.40	27.40	26.64	13.04	2.27	8.12	4.53
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	194.50	19.02	17.79	15.95	1.23	12.27	7.36
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	167.16	17.12	18.75	5.71	3.26	13.05	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	208.04	21.66	23.74	8.95	2.29	6.87	3.33
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	176.28	22.42	12.89	12.89	2.80	8.97	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	151.46	16.49	16.49	6.18	1.03	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	197.99	20.61	25.84	12.48	2.61	7.84	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	157.83	22.42	20.33	11.06	3.59	10.76	3.59
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	125.59	16.60	14.94	8.30	1.66	6.64	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	196.89	18.03	18.38	7.78	3.18	4.95	6.01
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	174.80	19.18	19.55	11.43	4.06	5.90	4.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	150.82	23.03	28.78	3.45	3.45	6.91	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	200.32	21.11	18.42	9.59	3.84	6.14	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	191.92	22.65	27.74	8.49	3.96	12.45	5.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	166.56	20.51	13.95	3.28	2.46	4.92	6.56
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	187.98	19.88	21.69	7.23	2.71	6.78	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	158.71	24.42	17.95	5.75	0.72	8.62	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	155.36	11.20	15.68	8.22	0.00	3.73	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	180.59	19.69	19.32	6.69	2.97	4.46	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	123.19	18.09	14.65	4.74	4.74	9.48	3.45
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	170.40	16.27	22.26	2.57	0.00	5.14	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	206.24	22.66	22.66	10.00	1.67	8.00	3.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	136.95	20.51	11.46	6.64	3.02	4.83	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	154.29	11.38	16.35	0.71	0.71	4.27	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	210.36	18.90	22.00	6.53	1.37	5.84	2.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	140.63	17.18	15.03	5.90	3.22	8.05	4.29
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	152.85	11.45	14.81	3.37	3.37	4.04	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	204.47	18.52	20.74	10.37	2.96	7.04	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	108.15	15.12	9.30	2.33	1.16	6.98	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	120.58	14.81	19.04	3.17	3.17	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	186.47	21.21	24.81	4.40	1.20	4.40	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	128.66	16.72	15.26	8.72	1.45	5.81	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	183.20	17.63	25.30	10.73	2.30	6.90	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	222.47	18.25	21.21	14.31	0.99	4.93	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	154.31	17.88	13.17	10.35	2.82	8.47	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	169.95	18.60	21.12	11.56	4.02	6.54	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	186.56	18.93	18.02	11.72	1.80	5.41	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	139.41	13.77	17.21	12.05	0.00	12.05	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	197.29	19.15	21.82	8.91	3.56	5.79	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	183.00	16.03	16.03	7.82	1.17	5.08	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	145.80	17.81	16.49	7.26	6.60	7.26	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	168.13	18.16	22.31	8.82	2.59	8.30	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	182.47	14.88	16.63	7.00	2.63	7.88	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	136.42	19.57	21.25	13.98	1.68	9.50	5.03
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	166.94	13.25	16.78	12.37	0.88	6.18	3.53
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	231.43	23.53	20.83	8.87	3.09	8.49	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	136.72	19.24	18.74	10.63	2.03	5.57	4.05
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	152.36	15.86	13.46	8.17	1.92	3.84	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	209.11	26.24	19.88	10.73	1.59	4.37	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	126.39	13.98	20.05	15.19	0.00	1.82	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	175.00	26.28	22.13	9.68	1.38	5.53	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	223.81	18.62	18.62	13.30	3.80	6.08	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	156.47	22.72	15.49	13.94	5.16	9.81	7.23
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	159.02	12.09	20.56	6.05	1.21	4.23	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	215.49	18.70	21.23	14.26	2.54	7.61	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	146.07	19.19	14.93	10.66	0.53	3.20	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	165.51	23.56	24.71	6.32	1.15	5.75	4.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	236.03	26.74	19.03	15.43	2.06	3.60	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	161.28	17.68	19.81	8.49	4.24	5.66	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	146.98	19.86	21.56	9.65	1.70	7.94	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	211.76	19.14	16.64	8.74	0.83	4.99	2.91
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	166.00	18.79	22.71	9.40	2.35	7.83	7.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	172.03	22.97	25.89	7.93	2.51	5.01	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	204.91	23.23	21.84	13.01	5.11	8.36	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	167.93	23.42	18.73	8.03	3.35	7.36	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	174.83	21.39	22.45	4.81	1.60	3.74	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	229.93	24.65	22.63	10.10	2.02	4.45	3.64
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	141.34	23.86	19.27	11.93	0.92	7.34	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	127.14	22.23	24.01	9.78	0.89	4.45	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	257.01	16.53	34.76	7.98	2.85	5.70	5.13
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	159.52	21.47	16.87	8.44	1.53	7.67	5.37
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	195.89	30.09	22.43	8.75	3.83	8.21	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	192.43	19.15	16.93	6.68	1.34	9.80	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	177.55	17.68	16.38	5.46	1.04	7.02	2.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	206.89	29.84	21.88	13.26	3.32	12.60	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	351.29	39.49	33.26	14.55	2.08	8.31	10.39
Macrophage - monocyte derived, donor1	11232-116C8	29.40	9.57	3.87	2.73	1.60	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	24.04	6.06	4.22	2.39	0.73	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	22.81	7.47	3.54	1.18	1.31	0.13	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	29.21	23.90	3.72	1.06	4.25	3.72	4.25
Mallassez-derived cells, donor2	11929-125I3	16.95	14.89	3.01	0.95	2.85	3.49	1.90
Mallassez-derived cells, donor3	11930-125I4	22.10	19.46	4.59	3.20	3.34	3.20	1.67
Mammary Epithelial Cell, donor1	11273-116H4	29.39	14.95	3.39	6.78	0.90	1.00	0.30
Mammary Epithelial Cell, donor2	11350-117G9	13.03	11.29	3.76	4.63	2.32	2.03	1.45
Mammary Epithelial Cell, donor3	11422-118F9	18.21	11.97	5.24	0.75	4.74	3.24	0.75
Mast cell - stimulated, donor1	11487-119E2	17.63	1.36	0.68	2.03	0.68	2.03	0.00
Mast cell, donor1	11563-120D6	26.39	3.46	3.68	2.27	0.97	0.65	0.00
Mast cell, donor2	11565-120D8	46.36	8.32	5.94	8.62	0.30	0.30	0.30
Mast cell, donor3	11566-120D9	61.91	11.48	8.78	10.36	6.30	0.00	0.00
Mast cell, donor4	11567-120E1	51.24	7.98	7.80	8.51	1.60	0.35	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	41.25	9.43	9.54	2.99	2.77	0.89	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	35.60	5.84	9.34	4.09	1.17	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	37.63	7.80	7.69	2.87	1.84	0.34	0.00
Mast cell, expanded, donor8	11941-126A6	35.48	1.84	5.52	2.01	0.67	0.84	0.00
Melanocyte - dark, donor1	11502-119F8	36.22	6.37	7.26	1.09	0.80	1.59	0.90
Melanocyte - dark, donor2	11582-120F7	42.22	24.23	11.77	1.04	8.65	4.85	1.73
Melanocyte - dark, donor3	11663-122F7	31.15	11.08	5.14	1.67	2.54	1.30	0.36
Melanocyte - light, donor1	11274-116H5	12.93	3.06	2.12	0.94	0.00	1.18	0.00
Melanocyte - light, donor2	11351-117H1	5.46	6.14	1.36	0.00	2.05	0.68	0.00
Melanocyte - light, donor3	11423-118G1	31.22	6.07	6.94	0.00	3.47	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	38.63	14.06	5.52	1.98	3.02	1.56	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	56.21	17.75	8.88	2.42	3.50	1.88	2.42
Melanocyte, donor3 (MC+3)	12837-137B2	42.32	11.25	5.36	1.34	2.14	1.07	0.80
Meningeal Cells, donor1	11493-119E8	7.20	12.90	7.20	3.10	2.61	1.49	0.50
Meningeal Cells, donor2	11573-120E7	22.45	20.25	9.24	1.76	7.92	1.76	0.44
Meningeal Cells, donor3	11654-122E7	34.23	23.31	14.10	2.61	5.71	5.95	2.28
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	45.05	47.34	12.55	2.85	13.12	3.42	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	41.56	9.66	5.84	1.61	1.61	1.31	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	2.63	0.00	0.00	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	14.39	26.16	1.31	2.62	7.85	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	58.13	53.10	14.35	5.02	10.05	4.31	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.15	9.11	3.39	1.27	1.91	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	23.62	14.07	6.03	2.51	2.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	27.69	29.23	3.74	3.08	6.37	2.64	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	34.34	51.87	16.07	7.31	10.23	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	28.85	40.92	6.14	3.07	10.03	2.66	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	16.34	16.48	7.06	2.49	4.02	1.11	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.06	6.69	1.12	1.49	3.35	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	26.45	11.05	3.95	1.84	3.16	1.58	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.65	7.12	0.89	0.89	0.89	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	11.68	0.00	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	31.38	36.50	5.12	1.92	7.04	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	41.82	46.79	13.11	2.84	9.92	2.48	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.33	7.82	5.63	1.25	3.44	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	56.60	75.47	14.51	2.18	9.43	4.35	5.08
Mesothelial Cells, donor1	11247-116E5	27.05	5.83	3.18	2.39	1.06	2.39	1.59
Mesothelial Cells, donor2	12156-128G5	38.04	13.51	9.51	1.50	2.00	1.50	2.00
Mesothelial Cells, donor3	11402-118D7	23.70	5.93	3.40	1.37	0.72	1.52	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	22.96	8.10	4.05	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	41.87	11.57	10.10	1.97	2.46	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	23.26	9.42	2.94	0.59	1.18	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	43.70	11.16	5.27	1.24	2.48	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	21.16	4.56	2.28	1.24	1.04	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	29.28	10.76	5.51	0.75	1.50	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.83	4.65	1.40	0.00	2.33	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.81	13.41	4.67	0.61	2.44	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.57	6.34	3.56	0.79	0.79	0.79	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.01	9.73	0.88	0.00	2.65	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	34.19	9.88	6.46	2.28	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.59	5.94	2.76	0.42	2.33	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	6.45	0.92	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.48	4.47	1.49	0.60	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	8.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	33.87	11.29	4.77	0.25	2.51	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	18.78	4.28	2.61	1.19	0.95	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.72	6.08	0.55	0.55	0.00	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	27.63	9.67	3.91	0.46	2.30	0.46	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	20.19	5.68	2.94	0.63	1.89	1.26	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.16	5.91	2.85	0.41	1.02	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.46	8.37	4.93	1.29	2.36	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.23	7.34	2.00	0.22	0.89	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	18.18	7.67	1.97	1.31	0.88	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.65	2.03	0.00	1.01	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	4.97	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.11	6.79	2.99	1.90	1.36	0.54	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.94	6.76	0.29	0.00	1.18	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	4.36	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.99	11.53	2.40	1.92	2.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	18.81	6.40	0.80	1.20	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	6.86	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.04	10.01	5.51	0.50	2.50	1.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	4.08	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	20.14	12.26	4.82	4.38	1.31	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	4.41	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	3.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	24.54	10.91	1.49	0.74	1.74	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	1.39	2.09	0.00	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	6.63	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	30.43	9.57	4.79	3.76	2.05	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.94	2.19	0.00	0.00	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.30	1.42	1.42	1.42	1.42	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	24.41	9.82	5.05	2.52	3.37	0.56	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.22	4.99	2.08	0.42	0.00	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.83	4.66	0.58	1.75	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	7.54	3.02	0.90	1.21	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.96	9.18	2.50	0.42	1.67	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	23.09	4.62	3.69	2.77	1.85	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.92	9.11	1.14	1.14	1.14	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.54	4.70	2.49	0.14	0.41	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	23.84	5.18	3.89	2.85	0.78	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.02	4.72	3.43	0.86	0.86	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	3.81	0.64	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.48	8.27	3.47	0.80	0.27	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	24.25	8.68	4.19	1.80	1.50	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.85	4.66	1.98	0.42	0.42	0.42	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	30.58	9.24	2.55	2.23	1.91	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.55	6.63	2.21	1.11	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	3.79	1.90	0.38	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	27.27	11.65	3.98	1.99	1.70	1.14	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.53	7.62	3.93	0.98	2.70	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	4.56	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	23.23	6.76	6.47	1.47	1.76	0.88	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.10	11.53	5.48	0.58	1.15	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.97	10.30	3.71	0.82	2.89	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	15.48	6.25	2.98	1.49	1.49	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	11.30	3.77	11.30	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	37.43	5.35	7.13	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	26.94	5.26	4.27	1.97	0.33	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	8.42	7.36	2.10	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	37.56	7.12	4.35	2.97	0.59	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	36.32	4.66	4.66	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	32.30	6.76	3.76	1.13	1.50	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.84	7.19	3.46	1.07	2.13	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	15.38	7.35	3.62	1.24	1.36	0.57	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	22.84	6.63	2.95	0.00	2.95	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.22	3.66	5.86	1.10	0.73	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	21.78	3.11	9.33	3.11	3.11	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	22.98	12.83	6.95	0.00	3.74	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	19.32	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	21.21	3.03	5.05	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	34.15	11.38	3.79	0.42	2.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	13.62	6.81	6.81	4.09	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	40.06	16.53	0.64	0.64	3.81	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	29.15	21.06	5.67	0.81	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	125.37	10.57	4.53	0.00	6.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	154.17	0.00	5.71	57.10	5.71	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	231.63	3.26	9.79	26.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	14.26	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	263.53	12.55	0.00	50.20	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	23.91	12.93	4.74	1.72	1.51	2.15	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	29.79	8.88	6.27	1.57	1.57	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.70	25.36	8.01	0.00	3.34	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.27	15.03	2.92	0.00	1.67	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	47.35	74.73	13.50	0.38	12.55	1.90	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	49.47	54.26	14.36	6.38	6.38	7.98	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.96	16.32	4.76	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	163.55	16.54	5.51	23.89	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.90	14.65	4.19	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.03	23.01	9.53	0.00	4.18	1.39	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.29	12.70	2.43	0.00	1.08	0.81	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.23	14.09	5.89	1.26	1.26	0.84	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	133.62	77.94	22.27	55.67	33.40	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	26.80	19.36	5.96	0.50	4.96	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	33.29	16.51	6.23	0.54	2.98	0.27	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.52	12.47	5.21	0.00	1.59	0.91	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.13	7.51	2.29	0.16	1.14	0.16	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	37.73	14.40	5.83	1.46	2.19	0.73	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	35.54	16.97	4.77	0.53	2.12	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.01	3.60	2.40	0.00	0.60	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	66.62	68.59	9.19	1.97	8.86	1.31	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	18.70	8.46	1.46	0.16	0.81	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	35.98	10.23	4.23	1.23	1.06	0.88	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	23.91	7.74	4.22	0.00	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	36.32	6.44	5.06	0.46	0.92	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	37.60	6.75	5.46	0.32	1.29	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	41.73	49.66	8.28	1.38	7.24	2.41	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	91.02	5.06	2.53	32.87	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	30.08	8.02	3.34	1.34	1.78	0.67	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	38.95	10.58	3.39	0.00	0.85	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	33.47	11.87	3.09	0.24	1.42	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	40.35	12.45	5.58	0.00	1.72	2.15	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	72.22	9.03	18.06	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.99	9.33	2.67	0.33	0.33	0.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	30.66	4.96	1.35	0.90	0.45	2.25	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	36.11	10.32	5.56	0.40	1.19	1.59	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	11.14	3.71	0.93	2.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	51.08	18.54	4.54	0.38	3.78	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.58	8.47	3.26	0.00	0.65	0.33	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	4.36	1.31	0.00	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	42.06	19.00	4.98	1.81	2.71	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	37.92	9.70	4.41	0.88	0.88	1.76	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	37.23	10.64	3.99	0.00	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	3.97	2.98	0.00	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.91	4.59	2.68	0.00	0.77	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.39	6.05	1.51	1.51	2.42	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	30.06	11.71	3.76	2.21	2.21	0.44	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	29.14	12.20	7.45	0.00	0.68	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	66.42	56.20	5.11	5.11	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	35.97	6.71	3.05	1.22	1.22	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.03	8.81	3.15	0.00	1.26	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.88	6.36	2.42	0.30	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.11	11.08	3.96	0.00	2.37	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	39.68	49.88	9.07	1.13	9.07	4.53	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	75.87	20.23	15.17	10.12	0.00	5.06
Myoblast, donor1	11241-116D8	39.88	37.39	8.82	1.86	7.83	2.24	2.98
Myoblast, donor2	11322-117D8	40.28	30.88	8.82	4.03	5.18	1.53	0.58
Myoblast, donor3	11398-118D3	34.98	14.97	6.89	2.35	2.69	1.01	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	26.27	4.23	3.36	2.19	1.17	1.17	0.29
Natural Killer Cells, donor1	11230-116C6	59.04	10.46	6.46	16.61	1.85	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	85.34	12.67	15.98	28.95	3.92	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	65.34	10.68	7.55	25.40	2.76	0.92	0.55
Neural stem cells, donor1	11275-116H6	28.67	10.16	7.62	1.81	1.45	3.27	0.00
Neural stem cells, donor2	11352-117H2	7.70	0.00	1.93	0.00	0.00	3.85	0.00
Neurons, donor1	11494-119E9	59.17	44.38	14.79	5.69	10.24	3.41	0.00
Neurons, donor2	11574-120E8	53.06	23.78	20.26	3.30	9.25	3.52	1.32
Neurons, donor3	11655-122E8	81.39	30.42	29.60	4.11	13.98	3.29	1.64
Neutrophils, donor1	11233-116C9	27.84	18.56	3.71	3.71	2.78	0.00	0.00
Neutrophils, donor2	11314-117C9	17.39	28.99	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	29.32	11.61	4.28	2.44	3.67	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	27.31	9.02	17.69	0.71	1.90	1.42	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	29.96	16.61	19.86	0.65	3.26	1.30	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	28.88	22.46	18.85	2.41	3.21	1.00	0.80
Olfactory epithelial cells, donor1	11933-125I7	55.20	8.81	6.61	2.20	1.51	1.24	0.83
Olfactory epithelial cells, donor2	11934-125I8	53.12	18.53	14.47	2.89	4.20	2.75	1.01
Olfactory epithelial cells, donor3	11935-125I9	67.88	13.28	7.04	1.48	2.61	0.91	0.79
Olfactory epithelial cells, donor4	11936-126A1	63.31	10.13	6.04	2.82	2.14	1.95	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	34.91	11.43	6.62	1.81	2.41	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	25.52	10.00	5.53	0.00	2.77	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	50.30	17.15	4.57	0.00	4.57	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	52.76	11.79	3.72	0.00	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	43.39	22.67	13.88	1.37	7.82	1.17	0.78
Osteoblast, donor2	11354-117H4	19.66	17.56	8.43	7.02	3.51	2.11	0.00
Osteoblast, donor3	11426-118G4	43.72	24.17	9.24	0.53	7.11	1.96	0.53
Pancreatic stromal cells, donor1	11249-116E7	39.42	14.99	6.49	1.52	3.29	1.35	0.34
Pericytes, donor1	11491-119E6	4.78	8.34	2.89	0.45	1.11	0.00	0.00
Pericytes, donor2	11571-120E5	29.20	21.28	9.96	1.13	4.30	0.23	0.23
Pericytes, donor3	11652-122E5	40.69	24.62	7.12	1.83	6.71	1.83	1.83
Perineurial Cells, donor1	11499-119F5	38.54	17.52	8.25	4.63	4.41	2.15	0.34
Perineurial Cells, donor2	11579-120F4	32.20	12.05	5.15	0.83	2.58	1.93	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	40.16	5.74	2.23	7.33	1.27	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	56.56	8.33	6.61	15.43	1.47	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	35.59	7.25	5.05	6.60	1.94	0.52	0.00
Placental Epithelial Cells, donor1	11278-116H9	46.88	43.29	6.46	2.87	5.98	2.39	0.96
Placental Epithelial Cells, donor2	11355-117H5	23.29	16.63	7.76	1.11	4.44	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	29.84	9.03	6.28	0.79	1.77	1.77	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	34.81	31.33	12.34	0.00	7.59	2.53	1.27
Preadipocyte - breast, donor1	11467-119B9	21.57	13.51	5.44	1.69	3.00	2.06	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.62	3.00	3.00	3.79	0.65	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	40.75	16.89	6.08	2.03	2.70	0.68	0.90
Preadipocyte - omental, donor1	11468-119C1	34.31	10.98	5.11	1.60	1.49	1.60	1.17
Preadipocyte - omental, donor2	11329-117E6	21.82	11.35	4.36	0.87	2.62	1.31	0.87
Preadipocyte - omental, donor3	11403-118D8	34.67	16.47	6.16	2.29	3.29	2.58	0.86
Preadipocyte - perirenal, donor1	11469-119C2	23.62	29.53	13.78	0.00	0.00	2.95	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	20.88	15.05	3.99	1.23	5.53	1.54	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	58.44	50.29	15.05	6.55	10.27	6.37	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	34.74	34.74	10.05	2.38	6.64	3.07	1.36
Preadipocyte - visceral, donor1	11280-116I2	30.09	25.34	6.52	5.22	4.84	3.54	1.02
Preadipocyte - visceral, donor2	11357-117H7	43.72	31.29	8.28	5.52	5.98	3.68	2.76
Preadipocyte - visceral, donor3	11429-118G7	34.80	43.68	18.81	3.66	7.31	3.76	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	40.43	12.52	4.37	6.64	1.96	2.87	0.91
Prostate Epithelial Cells, donor2	11331-117E8	24.78	13.95	6.50	2.03	1.62	2.84	1.76
Prostate Epithelial Cells, donor3	11404-118D9	38.89	12.43	2.14	3.00	3.06	0.55	0.49
Prostate Stromal Cells, donor1	11254-116F3	47.84	28.93	7.52	3.19	5.24	4.10	0.91
Prostate Stromal Cells, donor2	11332-117E9	51.10	30.12	8.61	3.23	7.35	3.77	0.54
Prostate Stromal Cells, donor3	11405-118E1	34.72	16.16	5.74	1.67	3.02	0.94	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.07	12.41	4.01	3.65	4.74	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	35.21	17.12	6.38	1.87	3.19	1.59	0.35
Renal Epithelial Cells, donor1	11517-119H5	7.61	12.68	2.03	0.51	2.54	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	24.90	28.45	8.54	1.42	4.27	0.71	2.13
Renal Epithelial Cells, donor3	11678-122H4	25.51	14.93	7.62	2.54	2.96	1.48	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.26	7.49	3.40	0.00	2.04	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	24.39	15.23	9.43	3.10	2.56	2.02	2.02
Renal Glomerular Endothelial Cells, donor3	11675-122H1	45.29	31.53	12.43	2.00	7.99	3.77	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	3.99	1.33	0.00	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	15.19	10.12	3.96	2.86	3.96	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	25.71	16.93	6.90	1.88	4.39	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	13.87	14.15	3.05	1.11	2.50	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.86	14.23	2.42	2.42	2.68	1.34	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	35.00	17.29	5.06	1.69	5.90	0.42	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	24.49	27.00	7.91	3.09	4.24	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	31.89	27.74	6.74	2.85	5.44	2.85	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	30.70	7.39	4.83	1.42	2.27	0.85	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	23.67	28.82	1.03	2.06	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	51.44	14.05	5.27	2.01	1.51	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	49.04	11.36	4.41	3.21	2.14	0.53	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	66.11	18.76	7.15	2.68	4.47	3.57	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	117.23	14.86	15.96	7.15	2.75	4.40	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	69.03	17.40	7.54	2.32	1.74	3.48	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	46.81	22.10	18.33	5.85	2.34	3.90	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	70.71	28.40	15.49	4.97	4.07	3.87	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	62.46	26.21	14.72	7.81	3.90	3.46	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	115.24	33.00	18.98	7.44	4.34	6.45	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	86.36	29.84	14.80	4.31	3.85	4.08	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	94.53	32.59	16.41	5.78	6.24	5.55	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	61.34	22.32	14.10	3.29	2.88	3.29	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	98.48	26.47	18.91	3.78	4.54	6.05	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	83.14	27.60	14.69	6.63	4.84	4.84	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	59.10	19.65	18.08	6.89	2.30	3.59	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	83.38	27.47	14.59	4.51	4.61	4.19	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	93.15	32.75	19.25	4.43	4.65	3.98	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	46.84	20.65	13.96	3.82	2.68	3.63	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	84.41	29.63	14.25	3.45	4.56	4.47	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	52.80	16.16	9.77	5.64	2.63	4.70	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	56.93	24.68	16.19	3.18	2.52	3.72	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	65.32	25.11	13.43	4.19	2.92	3.99	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	72.18	27.50	15.47	6.30	5.92	5.92	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	53.50	23.07	13.88	3.42	1.92	3.63	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	87.46	21.86	17.10	4.20	3.08	3.92	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	73.83	25.46	12.30	4.27	3.76	3.25	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	62.36	26.44	15.68	3.46	3.46	4.56	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	63.03	20.85	13.00	3.92	3.56	4.54	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	73.20	32.10	14.64	4.97	3.90	3.09	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	61.80	26.89	20.05	5.66	3.07	5.90	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	76.39	32.34	17.26	3.77	4.37	4.56	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	91.20	32.97	17.54	9.12	6.08	5.85	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	67.60	20.74	16.59	5.18	4.15	4.35	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	71.45	37.83	14.38	7.08	5.53	6.64	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	58.28	24.86	14.62	6.27	3.13	5.01	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	54.78	22.61	15.34	4.44	1.75	4.58	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	80.38	26.06	15.84	4.60	3.92	6.64	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	69.79	27.38	13.50	5.78	2.89	5.40	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	54.50	21.49	15.13	5.33	3.27	4.13	2.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	62.96	24.69	13.99	5.35	3.15	5.49	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	96.70	38.58	21.18	7.55	4.93	5.75	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	49.08	26.08	15.85	4.09	4.09	3.41	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	64.95	29.30	13.02	4.44	2.81	2.81	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	88.49	27.99	10.66	2.13	2.67	3.47	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	47.70	15.21	8.57	2.63	1.80	1.52	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	69.05	27.38	12.14	5.00	5.48	3.33	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	75.38	20.76	9.07	2.62	2.42	2.42	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	56.88	13.66	11.96	3.11	1.70	1.98	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	96.07	13.28	11.88	2.79	1.05	1.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	77.37	13.90	3.93	4.23	1.81	2.42	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	73.06	14.07	13.83	3.79	1.47	4.41	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	78.16	10.19	8.59	5.82	1.16	3.49	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	109.52	21.29	12.17	12.78	1.83	3.65	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	80.17	17.48	15.67	3.62	2.71	3.62	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	60.17	9.95	8.14	8.60	2.04	2.49	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	81.18	11.38	9.59	5.39	1.50	1.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	46.76	6.49	8.97	5.08	0.83	2.48	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	90.07	10.46	12.38	5.12	1.71	3.84	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	109.38	18.03	7.81	12.62	1.80	3.61	0.60
Schwann Cells, donor1	11498-119F4	15.99	34.98	8.84	2.82	6.77	0.75	0.75
Schwann Cells, donor2	11578-120F3	27.22	37.43	3.40	13.61	6.80	3.40	3.40
Schwann Cells, donor3	11659-122F3	37.90	37.46	17.53	2.63	8.33	2.85	0.88
Sebocyte, donor1	11220-116B5	17.53	9.31	3.29	1.10	1.10	2.74	0.55
Sebocyte, donor2	11301-117B5	25.28	10.57	5.51	1.38	2.76	4.14	0.92
Sebocyte, donor3	11378-118B1	35.66	9.07	3.09	1.44	2.06	1.03	1.24
Sertoli Cells, donor1	11255-116F4	44.73	16.57	6.63	3.31	8.28	6.63	0.00
Sertoli Cells, donor2	11333-117F1	59.31	19.77	11.30	5.65	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	55.34	14.16	4.93	4.40	2.73	0.88	0.26
Skeletal Muscle Cells, donor2	11358-117H8	76.62	15.18	7.23	0.72	2.89	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	59.36	65.21	25.92	3.34	18.39	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	67.39	58.60	23.25	8.01	12.25	5.81	2.20
Skeletal Muscle Cells, donor5	11455-119A6	47.57	48.76	21.11	8.03	8.03	3.86	2.68
Skeletal Muscle Cells, donor6	11459-119B1	52.79	59.71	24.01	7.70	12.47	4.62	2.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	37.42	27.47	10.84	3.15	6.55	1.89	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	24.40	27.82	10.84	3.85	5.14	0.86	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	44.55	39.09	12.50	3.57	7.74	2.18	1.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	48.95	11.63	6.32	2.11	2.27	1.85	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	36.91	36.91	10.86	0.72	2.17	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	37.01	49.12	14.72	1.51	9.91	0.96	0.14
Skin - palm, donor1	10286-104F7	16.12	2.69	2.69	8.06	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	32.00	19.46	4.04	0.29	2.88	3.46	1.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	11.45	13.09	1.64	29.44	3.27	1.64	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	34.79	21.55	5.06	0.39	3.76	2.73	3.12
Small Airway Epithelial Cells, donor1	11256-116F5	32.67	15.01	4.03	1.67	2.92	1.95	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	37.70	12.52	2.53	2.67	0.84	1.13	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	81.83	6.77	2.33	38.27	1.27	0.42	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	25.03	8.84	2.55	2.02	1.27	0.37	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	51.22	45.05	12.65	0.00	7.71	4.01	2.78
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.56	6.89	2.45	4.67	1.11	1.11	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	48.20	27.04	5.29	1.76	5.29	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	34.70	8.62	5.30	1.10	0.88	1.99	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	32.29	24.81	5.51	0.00	6.30	1.97	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	39.40	27.04	5.41	3.09	6.18	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	64.05	13.01	8.01	4.00	3.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	34.07	19.30	8.78	0.80	3.73	3.06	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	44.33	32.36	11.08	3.99	3.99	5.54	3.10
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	39.69	43.02	17.28	1.28	6.91	4.35	4.23
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.16	22.14	10.42	2.60	4.56	2.60	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	41.35	15.06	7.09	1.48	3.25	1.48	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	37.16	17.80	4.84	0.85	4.27	1.99	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.97	19.20	3.09	0.81	4.88	0.65	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.62	12.48	2.74	0.61	3.96	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	30.31	16.16	9.09	1.77	3.28	1.77	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	18.36	12.24	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	51.50	31.95	12.40	0.48	6.20	2.38	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	48.08	22.86	6.64	3.10	6.05	1.62	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	47.78	27.98	7.96	0.86	7.10	0.65	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	45.34	30.33	9.45	3.15	5.88	2.31	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	44.86	16.55	6.81	0.31	3.56	1.39	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	51.74	45.27	14.01	1.08	10.78	7.55	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	46.02	40.05	14.64	0.90	7.17	3.59	2.39
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12.63	17.07	3.07	1.37	5.80	0.34	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	35.73	7.93	4.08	2.04	2.36	0.63	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	23.15	23.45	7.25	2.01	4.53	1.71	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	44.60	19.57	9.10	3.64	2.28	2.96	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.74	44.68	10.87	1.21	13.89	1.21	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	62.26	33.12	11.13	5.03	10.60	7.42	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.83	20.64	8.92	2.66	2.66	0.67	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	48.33	25.80	8.89	3.26	6.39	3.26	1.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.93	8.88	7.36	1.52	1.27	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	44.63	15.53	6.48	1.21	3.17	1.36	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	46.51	21.00	9.00	0.75	5.25	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	42.64	16.80	6.46	0.00	1.29	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	35.81	23.72	13.02	0.47	8.84	1.40	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	47.46	26.25	7.07	2.52	2.52	6.56	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	34.47	24.44	9.09	1.25	3.13	3.13	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	14.45	17.11	3.83	1.47	2.95	1.18	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	36.49	34.74	9.08	1.25	7.50	3.00	1.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	37.84	20.56	3.27	0.47	3.74	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	30.65	16.41	7.05	1.01	3.45	1.87	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	52.01	32.63	12.75	2.29	7.39	1.53	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	49.45	35.91	15.04	1.50	9.78	3.01	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	36.61	24.04	8.24	1.82	5.45	1.96	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	54.13	16.51	6.87	0.25	4.44	1.01	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.05	5.24	2.38	0.00	3.81	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	29.85	19.33	7.10	0.24	6.36	2.69	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	34.25	15.69	11.05	2.21	2.87	1.99	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	57.64	36.86	12.29	3.80	11.41	2.05	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	29.74	8.36	5.25	1.94	2.92	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	31.21	26.97	6.88	0.26	5.02	2.38	2.91
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	62.12	53.19	10.41	2.60	11.53	3.35	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	51.39	30.90	3.95	1.80	6.11	2.16	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	34.64	32.65	7.67	2.27	8.23	3.41	3.12
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	45.29	39.78	13.00	7.09	7.09	6.70	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	41.90	29.20	6.35	1.78	5.08	2.03	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	30.75	16.37	5.19	2.80	3.59	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	48.49	15.05	6.27	2.93	1.67	0.84	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	33.46	15.13	5.04	3.21	1.38	0.92	0.46
Synoviocyte, donor1	11291-117A4	35.85	9.93	7.07	4.21	2.19	1.01	0.50
Synoviocyte, donor2	11368-117I9	35.20	11.90	8.72	2.18	1.84	1.34	0.67
Synoviocyte, donor3	11440-118H9	27.26	9.16	4.47	2.01	1.56	1.12	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	16.44	25.73	4.29	2.50	3.57	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	13.87	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.80	12.04	2.32	0.23	2.08	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	27.53	12.62	4.87	3.23	2.51	1.22	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	29.77	18.94	7.34	0.39	3.87	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	25.20	13.74	5.73	1.15	2.86	2.29	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.70	11.81	3.69	4.06	2.71	1.11	0.12
Urethra, donor2	10319-105A4	25.18	23.38	5.40	5.40	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	10.89	11.95	3.19	1.59	1.86	1.06	0.27
Urothelial Cells, donor2	11600-120H7	11.62	19.23	2.80	3.61	6.81	0.80	0.80
Urothelial Cells, donor3	11681-122H7	15.59	8.94	4.58	1.60	1.60	0.69	0.46
Urothelial cells, donor0	11216-116B1	28.53	10.25	3.34	1.56	2.45	0.89	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	61.40	12.46	13.35	6.23	6.23	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	92.92	27.16	17.16	14.30	5.72	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	221.78	13.69	6.85	8.90	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	215.56	9.64	9.99	5.51	3.44	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	177.21	9.88	6.97	8.72	1.74	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	61.43	23.95	9.37	11.45	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	63.33	18.36	9.18	8.26	7.34	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	223.66	17.35	11.87	6.39	4.56	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	32.69	24.06	12.46	3.82	3.82	4.56	1.48
Wilms' tumor cell line:HFWT	10597-108E3	36.08	12.32	2.64	5.28	3.52	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	65.36	42.46	14.80	7.26	7.26	5.59	1.12
achilles tendon, donor2	10292-104G4	26.86	4.13	2.07	8.27	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	93.82	18.61	16.83	11.73	2.04	7.14	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	40.40	14.16	7.89	8.13	3.02	7.89	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	37.04	8.07	7.72	4.51	2.02	2.14	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	49.80	22.86	21.50	7.35	4.35	13.33	4.08
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.87	8.99	5.90	6.46	2.25	1.41	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	53.72	16.71	15.65	7.61	2.33	2.75	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	70.50	10.34	4.90	11.71	1.36	3.27	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	55.08	22.03	7.49	18.07	5.73	3.53	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	31.44	16.33	10.21	12.66	1.23	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	69.12	10.10	12.81	14.76	1.94	4.27	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	30.91	26.86	7.36	12.51	6.99	3.86	3.68
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	78.01	27.30	11.70	23.40	7.80	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	56.70	23.47	16.50	6.51	5.11	5.11	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	61.88	40.39	18.38	17.86	4.14	7.77	3.88
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	50.27	19.87	7.31	11.11	1.17	2.34	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.98	12.08	4.65	4.65	2.79	3.25	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.45	18.92	4.52	2.47	5.76	2.06	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	22.71	20.57	9.52	0.92	3.38	4.60	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	43.10	14.93	9.81	3.84	4.27	2.99	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	34.88	11.53	6.98	3.94	3.64	3.94	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	39.72	18.53	10.35	3.85	2.65	4.81	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	24.72	20.71	5.79	9.36	4.45	5.35	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	49.03	43.69	9.67	14.68	9.67	6.00	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	52.03	57.60	22.30	0.00	3.72	7.43	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	41.81	36.54	13.18	7.16	8.29	4.52	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	27.04	6.11	9.59	6.54	0.44	3.49	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	29.99	29.99	13.12	5.62	9.37	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	41.21	12.72	4.24	1.41	2.12	2.12	0.94
adipose tissue, adult, pool1	10010-101C1	27.77	6.20	2.48	0.47	2.33	0.16	0.00
adipose, donor1	10184-103D4	197.03	226.35	51.60	23.46	32.25	1.76	3.52
adipose, donor2	10185-103D5	95.70	34.47	33.25	8.11	6.08	0.41	0.41
adipose, donor3	10186-103D6	95.03	48.74	31.86	12.80	4.63	2.45	1.91
adipose, donor4	10187-103D7	52.01	51.14	19.07	20.80	4.33	8.67	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	66.76	24.46	15.62	3.95	5.37	6.31	2.05
adrenal gland, adult, pool1	10081-102A9	43.65	14.55	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	27.48	36.02	12.67	8.94	10.54	1.60	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	78.25	38.95	26.08	7.50	5.72	5.36	2.86
amniotic membrane cells, donor1	12235-129G3	38.49	9.97	9.51	5.10	1.85	1.39	0.46
amniotic membrane cells, donor2	12236-129G4	41.92	7.44	10.14	4.06	1.69	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	42.13	14.73	9.43	7.37	3.54	2.95	0.29
amygdala - adult, donor10196	10167-103B5	43.87	23.72	33.20	2.37	5.93	4.74	3.56
amygdala, adult, donor10252	10151-102I7	56.77	45.42	35.69	2.03	12.98	3.65	1.01
amygdala, newborn, donor10223	10360-105E9	85.53	41.31	27.76	3.87	13.23	6.78	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	33.23	7.26	2.55	4.46	1.15	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	70.16	46.33	12.13	14.56	11.69	12.35	4.63
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	31.40	12.03	11.69	7.01	1.34	6.01	0.00
aorta, adult, pool1	10052-101G7	33.34	13.53	8.43	2.94	4.12	0.39	0.39
appendix, adult	10189-103D9	56.67	13.58	6.21	5.43	1.55	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	73.60	22.01	20.98	4.47	3.44	8.94	2.41
artery, adult	10190-103E1	40.76	58.42	17.66	5.43	12.23	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	22.74	5.94	9.27	3.33	2.03	1.45	0.72
b cell line:RPMI1788	10427-106D4	52.79	10.71	4.61	8.48	2.83	1.34	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	41.89	21.36	8.32	1.94	6.10	2.50	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	31.06	11.01	4.37	3.87	1.98	2.98	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	64.94	11.55	8.20	7.53	2.01	3.18	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	51.45	11.18	6.71	8.39	4.47	0.56	1.12
bladder, adult, pool1	10011-101C2	40.96	12.82	5.21	1.20	3.04	0.33	0.11
blood, adult, pool1	10053-101G8	135.09	17.72	4.43	8.86	6.64	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	22.27	25.69	6.85	3.43	8.56	3.43	0.86
bone marrow, adult	10192-103E3	29.69	13.50	14.85	6.75	4.72	4.05	2.70
brain, adult, donor1	10084-102B3	41.00	25.63	37.93	2.05	10.25	2.05	0.00
brain, adult, pool1	10012-101C3	41.31	25.06	30.51	1.11	6.35	2.45	1.45
brain, fetal, pool1	10085-102B4	96.17	16.03	16.03	0.00	5.34	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	178.40	18.50	15.20	8.92	1.65	4.63	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	32.58	11.86	5.37	7.61	1.62	1.50	0.12
breast, adult, donor1	10080-102A8	35.36	4.42	1.89	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	44.72	24.52	10.93	6.99	7.62	2.03	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	55.97	21.95	8.66	10.82	3.71	1.86	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	139.51	119.48	17.96	12.20	22.56	5.76	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	56.89	23.48	12.59	13.31	3.87	5.81	2.91
carcinoid cell line:NCI-H1770	10703-109H1	33.85	24.45	6.11	9.87	4.23	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	53.49	20.45	5.58	3.94	3.39	3.50	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	88.73	28.84	17.75	10.46	3.49	4.75	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	76.39	25.02	14.91	6.65	6.92	5.32	1.06
caudate nucleus - adult, donor10196	10177-103C6	39.14	46.05	34.54	2.30	12.66	2.30	2.30
caudate nucleus, adult, donor10252	10164-103B2	64.59	34.13	23.76	2.01	8.70	2.18	2.01
caudate nucleus, adult, donor10258	10379-105H1	67.24	55.02	26.74	0.76	24.45	1.53	1.53
caudate nucleus, newborn, donor10223	10354-105E3	122.69	31.50	27.10	2.56	7.69	4.03	1.46
cerebellum - adult, donor10196	10173-103C2	46.61	29.13	14.57	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	71.53	21.56	12.60	3.20	6.19	1.07	0.43
cerebellum, adult, pool1	10083-102B2	45.19	24.84	18.63	1.72	10.00	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	122.88	26.57	8.30	7.47	9.13	3.32	1.66
cerebral meninges, adult	10188-103D8	54.21	43.62	52.95	1.76	9.33	3.78	1.51
cerebrospinal fluid, donor2	10294-104G6	18.27	35.08	13.89	0.73	5.85	2.92	2.19
cervical cancer cell line:D98-AH2	10552-107I3	23.58	15.38	5.46	1.87	4.60	0.86	0.29
cervical cancer cell line:ME-180	10553-107I4	45.07	7.46	4.14	5.80	0.33	2.49	0.17
cervix, adult, pool1	10013-101C4	71.81	12.91	8.08	2.83	3.15	0.73	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	15.33	7.25	12.26	3.07	2.37	2.65	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	7.84	5.23	2.61	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	109.49	17.90	6.59	6.34	2.11	1.99	0.50
choriocarcinoma cell line:SCH	10785-110H2	60.50	7.52	4.81	11.21	1.60	2.59	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	93.21	20.87	3.79	8.06	1.90	2.37	0.95
chorionic membrane cells, donor1	12238-129G6	55.27	11.68	5.98	7.98	1.14	1.42	0.85
chorionic membrane cells, donor2	12239-129G7	30.62	14.32	5.47	1.89	3.18	0.89	0.50
chorionic membrane cells, donor3	12240-129G8	75.28	13.19	9.34	7.69	1.10	0.55	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	44.43	42.41	14.14	7.07	10.10	8.08	6.06
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	32.85	15.18	10.57	6.92	1.34	1.73	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	16.26	10.56	3.38	3.38	1.90	1.90	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	42.37	60.86	9.50	7.70	20.03	1.80	2.82
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	49.10	57.33	10.64	6.05	21.29	3.87	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	41.74	42.76	7.33	4.48	9.16	1.83	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	54.47	75.38	15.61	8.24	18.55	7.95	3.24
chronic myelogenous leukemia cell line:KU812	10409-106B4	11.47	5.21	16.16	4.43	1.82	3.91	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	51.89	34.29	24.69	8.46	8.00	5.26	2.51
clear cell carcinoma cell line:TEN	10636-108I6	95.95	20.47	11.80	5.73	3.64	3.30	0.87
colon carcinoma cell line:CACO-2	10513-107D9	41.92	14.09	9.52	4.39	1.46	5.13	0.92
colon carcinoma cell line:COLO-320	10420-106C6	57.39	29.27	8.36	7.60	6.08	1.90	0.38
colon, adult, donor1	10082-102B1	46.41	8.33	9.52	0.00	4.76	0.00	0.00
colon, adult, pool1	10014-101C5	47.00	9.52	7.05	3.17	2.12	0.71	0.00
colon, fetal, donor1	10070-101I7	92.08	13.60	10.51	3.09	2.47	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	27.50	0.00	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	52.27	15.72	11.90	22.52	2.97	9.35	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	57.20	23.55	19.92	10.72	2.57	13.43	5.28
cord blood derived cell line:COBL-a untreated	10449-106F8	71.07	27.50	21.43	13.68	3.95	14.24	3.95
corpus callosum, adult, pool1	10042-101F6	13.49	13.49	6.63	2.76	3.65	0.33	0.33
cruciate ligament, donor2	10295-104G7	34.85	17.02	2.43	4.05	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	40.13	13.64	7.22	0.80	2.41	0.00	0.00
diencephalon, adult	10193-103E4	34.80	36.00	24.96	2.40	9.84	1.44	2.40
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	117.56	46.61	22.73	18.37	11.02	7.12	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	32.82	19.49	7.44	10.00	1.03	4.36	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	66.20	6.74	4.33	6.26	1.20	1.20	0.96
ductus deferens, adult	10196-103E7	52.33	17.94	11.46	3.99	1.00	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	74.89	11.52	8.64	2.88	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	46.35	11.03	10.30	9.56	3.68	0.74	1.47
dura mater, adult, donor1	10041-101F5	33.70	8.51	5.12	2.23	2.81	0.83	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	74.62	27.76	11.99	12.44	3.11	6.66	3.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	72.22	34.96	16.62	13.18	7.02	8.60	5.16
embryonic pancreas cell line:1B2C6	10604-108F1	61.04	30.21	10.48	1.23	4.32	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	63.57	27.24	11.20	3.63	4.84	5.45	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	59.90	25.32	12.66	3.70	4.01	5.25	0.93
embryonic pancreas cell line:2C6	10603-108E9	64.36	28.90	7.88	7.88	9.19	7.88	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	141.79	21.79	16.76	14.41	3.35	5.03	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	56.73	10.87	10.15	2.90	3.44	1.99	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	48.57	32.00	10.29	2.89	7.40	8.68	1.77
epidermoid carcinoma cell line:A431	10426-106D3	14.34	11.34	4.89	4.78	1.67	1.78	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	20.13	13.31	6.16	4.51	3.19	4.40	1.10
epididymis, adult	10197-103E8	42.70	17.37	10.88	2.93	4.40	0.84	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	52.51	10.47	5.32	3.02	3.02	2.48	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	22.41	9.04	2.75	0.79	2.75	1.97	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	59.10	39.71	14.94	10.88	9.57	12.06	3.41
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	46.16	20.67	8.46	6.99	2.85	6.69	2.56
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	49.97	30.36	15.91	10.64	7.73	10.64	4.03
esophagus, adult, pool1	10015-101C6	43.96	9.98	7.01	1.17	2.97	1.06	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	138.89	8.89	7.64	1.63	1.63	0.88	0.50
eye - muscle inferior rectus, donor1	10272-104E2	38.63	19.32	7.24	14.49	2.41	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	14.73	27.35	10.52	0.00	4.21	2.10	0.00
eye - muscle medial, donor2	10299-104H2	10.42	23.81	2.98	4.46	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	26.37	18.34	4.59	3.44	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	11.66	5.83	5.83	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	61.78	16.78	9.41	1.02	4.32	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	30.39	22.82	8.98	1.80	5.13	6.41	4.23
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	85.00	58.17	12.58	13.53	16.38	9.26	4.04
frontal lobe, adult, pool1	10040-101F4	33.78	21.02	26.74	0.75	6.47	1.97	1.50
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	43.54	6.61	14.71	12.31	1.20	6.91	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	16.28	14.63	3.57	1.28	4.11	0.27	0.00
gall bladder, adult	10198-103E9	36.21	12.31	5.55	2.90	4.10	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	109.52	21.47	15.57	20.94	6.44	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	73.95	27.64	14.57	16.43	4.48	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	36.54	16.05	14.79	3.80	2.96	5.70	1.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	56.28	30.17	8.12	5.61	4.84	3.87	1.35
gastric cancer cell line:AZ521	10549-107H9	56.89	15.58	9.51	4.92	2.30	2.46	0.98
gastric cancer cell line:GSS	10560-108A2	56.74	21.05	6.41	4.58	3.66	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	101.21	12.79	12.11	11.88	2.51	9.82	2.74
giant cell carcinoma cell line:LU65	10487-107B1	76.99	42.68	6.08	6.43	19.51	2.07	1.38
giant cell carcinoma cell line:Lu99B	10433-106E1	10.50	9.10	2.10	3.36	2.24	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	41.40	32.17	6.98	7.73	3.49	5.49	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.88	11.19	5.70	2.85	2.22	2.11	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.92	8.71	4.35	1.26	2.11	1.12	0.28
glioblastoma cell line:T98G	10485-107A8	32.78	16.11	5.63	2.32	6.40	2.65	0.33
glioma cell line:GI-1	10413-106B8	52.72	7.61	4.10	1.17	2.34	2.34	0.29
globus pallidus - adult, donor10196	10175-103C4	28.43	41.55	15.31	3.64	6.56	2.19	0.73
globus pallidus, adult, donor10252	10161-103A8	44.91	34.42	16.84	4.39	9.52	2.69	1.95
globus pallidus, adult, donor10258	10367-105F7	38.34	53.40	26.01	2.74	17.80	2.74	4.11
globus pallidus, newborn, donor10223	10364-105F4	76.21	28.24	15.99	3.73	5.86	2.13	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	0.00	0.00	0.00	0.00	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	10.93	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	31.36	10.45	15.68	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	32.96	16.96	5.12	2.24	2.24	1.28	0.32
hIPS +CCl2, biol_rep1	14383-156B9	22.96	73.92	21.58	6.89	7.80	12.86	5.97
hIPS +CCl2, biol_rep2	14384-156C1	16.46	58.53	17.83	10.06	6.86	13.26	3.20
hIPS +CCl2, biol_rep3	14385-156C2	23.83	66.34	15.46	7.73	6.44	13.53	5.80
hIPS, biol_rep1	14380-156B6	25.87	60.37	7.19	24.43	7.19	25.87	8.62
hIPS, biol_rep2	14381-156B7	24.01	67.90	8.92	18.52	3.43	10.97	6.86
hIPS, biol_rep3	14382-156B8	5.52	47.45	18.76	1.10	6.62	6.62	1.10
hairy cell leukemia cell line:Mo	10712-109I1	53.45	24.14	10.92	15.80	5.46	6.90	2.59
heart - mitral valve, adult	10205-103F7	41.26	16.44	6.58	3.89	3.29	1.20	0.00
heart - pulmonic valve, adult	10206-103F8	23.53	17.78	10.20	1.83	5.23	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	61.62	26.64	9.99	9.16	2.50	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	45.10	24.08	19.18	2.86	5.31	3.47	0.61
heart, adult, diseased, donor1	10051-101G6	29.38	37.90	15.33	0.00	9.79	1.28	0.43
heart, adult, pool1	10016-101C7	42.78	16.10	17.02	0.23	4.83	1.38	0.46
heart, fetal, pool1	10046-101G1	61.09	9.65	9.96	1.95	2.88	0.72	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	35.79	12.96	4.32	2.47	2.47	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	73.73	44.00	15.46	3.57	2.38	3.57	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	54.70	15.25	11.71	5.97	2.21	5.86	1.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	55.83	17.84	11.89	6.68	2.31	5.22	1.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	58.21	13.74	10.61	6.77	2.32	5.46	1.62
hepatoma cell line:Li-7	10484-107A7	60.84	19.80	10.68	6.12	4.11	5.89	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	27.64	18.19	11.36	5.23	3.82	7.24	2.41
hippocampus - adult, donor10196	10169-103B7	48.26	35.01	26.50	2.84	9.46	3.79	3.79
hippocampus, adult, donor10252	10153-102I9	43.68	37.15	23.88	1.43	7.55	3.27	1.43
hippocampus, adult, donor10258	10374-105G5	9.46	32.86	11.45	1.00	7.47	6.97	1.49
hippocampus, newborn, donor10223	10363-105F3	65.56	28.20	32.08	3.52	11.98	2.82	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	182.49	173.34	57.37	42.72	20.14	37.84	11.60
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	107.41	62.64	27.69	18.85	5.69	12.76	3.73
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	93.69	67.54	28.69	18.79	7.11	14.73	5.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	71.05	70.48	14.66	3.95	12.41	2.26	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	117.74	93.47	40.54	8.52	12.14	3.10	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	97.18	97.18	22.40	11.39	11.77	3.04	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	113.57	88.17	34.45	14.89	11.39	6.42	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	135.72	58.60	36.19	12.49	10.56	4.09	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	125.12	53.39	35.45	15.85	13.76	5.00	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	106.32	48.31	36.70	7.34	8.52	6.63	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	140.15	53.20	39.70	11.25	9.64	9.00	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	122.54	38.38	45.78	9.43	11.45	6.06	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	88.10	43.35	22.53	15.49	5.16	11.42	5.01
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	89.42	59.94	55.52	19.65	6.39	15.72	8.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	189.39	193.75	54.98	42.76	17.46	37.53	16.58
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	113.02	57.27	24.44	7.83	7.64	2.10	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	82.42	46.22	25.73	1.74	7.85	1.74	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	165.92	145.93	36.48	7.50	16.49	5.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	147.89	56.14	33.16	7.16	13.00	1.32	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	153.69	52.29	51.38	5.00	16.37	1.82	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	116.21	61.71	27.25	9.40	12.84	2.51	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	141.42	36.91	37.23	5.06	8.17	6.21	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	105.09	41.22	32.22	7.55	6.97	2.90	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	92.67	43.94	26.31	4.18	6.28	4.18	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	104.57	58.38	34.55	15.33	7.02	14.59	5.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	87.58	51.64	31.95	18.83	6.56	11.13	4.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	122.49	132.29	47.77	26.95	14.29	31.85	9.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	83.44	70.42	26.76	3.87	7.75	3.17	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	67.15	49.73	22.17	5.38	7.29	2.53	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	69.60	55.38	23.00	6.66	9.68	1.51	2.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	87.39	53.78	33.61	6.21	7.76	2.07	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	87.01	47.82	40.51	11.29	9.96	6.64	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	74.65	52.85	24.63	7.70	10.26	5.39	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	86.66	42.44	43.46	8.69	8.44	10.48	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	111.31	46.19	44.68	9.09	6.82	9.09	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	109.89	58.47	39.65	11.76	10.08	8.07	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	73.18	63.52	26.08	16.42	6.52	14.49	5.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	131.92	120.33	44.12	30.30	13.37	24.07	14.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	81.95	67.81	31.22	22.44	5.85	15.61	6.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	65.40	50.73	18.34	8.86	7.33	2.44	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	312.31	735.23	81.33	84.58	97.60	16.27	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	99.28	126.09	31.44	10.92	19.19	3.64	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	95.78	68.96	36.67	9.85	16.97	2.74	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	87.94	61.88	24.61	10.49	11.58	2.53	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	76.16	81.14	23.84	12.46	11.74	4.63	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	62.06	41.77	17.90	9.55	8.35	4.77	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	80.31	28.03	25.32	4.88	5.55	2.57	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	84.86	60.34	36.10	11.31	9.97	5.93	2.96
immature langerhans cells, donor1	11904-125F5	31.72	12.83	10.41	8.72	4.36	3.15	1.70
immature langerhans cells, donor2	11905-125F6	121.99	20.60	11.88	24.56	2.38	0.79	2.38
insula, adult, pool1	10039-101F3	43.53	23.37	24.89	0.95	5.96	3.60	1.80
keratoacanthoma cell line:HKA-1	10791-110H8	68.93	19.51	8.45	9.43	1.95	4.88	1.63
kidney, adult, pool1	10017-101C8	32.84	12.52	5.71	2.10	2.60	1.10	0.20
kidney, fetal, pool1	10045-101F9	32.96	5.80	3.96	1.98	1.41	0.64	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	72.86	17.18	9.37	4.40	2.70	6.25	2.13
large cell lung carcinoma cell line:NCI-H460	10839-111E2	72.72	12.17	10.78	5.39	1.52	2.21	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	38.17	11.56	6.79	9.73	2.57	4.59	1.28
left atrium, adult, donor1	10079-102A7	35.42	18.52	12.53	0.54	5.45	0.54	0.00
left ventricle, adult, donor1	10078-102A6	38.94	27.31	15.68	0.51	6.07	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	38.85	31.74	10.12	6.02	5.75	4.65	1.64
leiomyoma cell line:10964C	10569-108B2	38.80	49.94	12.57	1.44	14.01	4.67	2.51
leiomyoma cell line:15242A	10570-108B3	29.89	47.83	9.24	0.54	10.87	5.98	2.72
leiomyoma cell line:15425	10571-108B4	32.05	35.21	8.26	2.91	8.74	4.37	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	25.40	12.70	0.00	6.35	12.70	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	33.46	38.69	11.50	4.18	18.82	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	42.03	22.79	18.06	6.38	3.90	6.26	2.83
liposarcoma cell line:KMLS-1	10782-110G8	58.11	11.87	5.78	2.34	3.59	0.62	0.62
liposarcoma cell line:SW 872	10726-110A6	22.17	8.89	5.85	1.83	2.56	1.83	0.73
liver, adult, pool1	10018-101C9	30.14	13.29	6.00	0.81	2.43	0.81	0.16
liver, fetal, pool1	10086-102B5	37.63	16.93	6.58	0.94	2.82	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	53.37	29.75	18.23	2.04	6.12	1.75	2.04
locus coeruleus, adult, donor10252	10165-103B3	49.09	33.77	18.46	3.32	9.04	1.85	1.66
locus coeruleus, adult, donor10258	10375-105G6	71.66	52.48	42.60	0.85	8.75	5.36	3.95
locus coeruleus, newborn, donor10223	10362-105F2	127.03	45.01	32.81	5.05	15.14	6.73	5.05
lung adenocarcinoma cell line:A549	10499-107C4	33.08	8.17	4.71	3.88	2.49	1.80	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	28.27	29.64	4.14	2.07	8.27	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	53.78	27.68	8.30	3.69	3.03	3.03	1.85
lung, adult, pool1	10019-101D1	53.98	6.38	3.43	1.65	1.77	0.12	0.12
lung, fetal, donor1	10068-101I5	15.13	7.14	15.98	4.85	1.71	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	38.95	11.00	8.25	2.75	0.92	0.92	0.00
lymph node, adult, donor1	10077-102A5	36.45	9.94	8.99	0.47	3.31	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	50.41	10.96	5.70	4.60	1.97	1.53	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	110.18	37.88	21.88	13.13	8.60	3.92	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	31.43	14.44	7.65	17.84	2.55	8.49	2.55
mature adipocyte, donor1	12231-129F8	31.97	7.10	6.66	1.78	1.78	0.00	0.00
mature adipocyte, donor2	12232-129F9	21.58	9.34	4.77	1.45	2.49	0.83	0.42
mature adipocyte, donor3	12233-129G1	17.54	9.72	7.11	0.47	1.19	0.24	0.00
mature adipocyte, donor4	12234-129G2	32.64	9.48	9.21	0.53	4.21	1.32	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	50.75	25.97	12.39	7.15	5.24	1.91	2.14
medial frontal gyrus - adult, donor10196	10170-103B8	49.63	33.84	54.15	1.13	3.38	4.51	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	55.91	27.77	28.51	1.84	6.62	1.84	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	37.17	53.69	47.97	0.95	10.80	3.81	5.08
medial frontal gyrus, newborn, donor10223	10352-105E1	124.96	118.99	60.99	4.26	26.02	12.79	7.25
medial temporal gyrus - adult, donor10196	10183-103D3	88.26	57.54	100.58	1.18	15.86	5.74	3.88
medial temporal gyrus, adult, donor10252	10156-103A3	53.48	33.53	27.59	1.91	7.00	2.12	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	34.67	21.19	3.85	7.71	9.63	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	186.60	186.60	0.00	14.35	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	76.45	37.69	45.58	2.51	10.05	2.51	3.59
medulla oblongata - adult, donor10196	10174-103C3	29.20	26.61	12.33	5.84	7.14	3.24	2.60
medulla oblongata, adult, donor10252	10155-103A2	34.68	21.98	11.92	1.39	6.66	0.77	1.24
medulla oblongata, adult, pool1	10038-101F2	18.77	15.35	8.90	1.14	3.43	1.47	0.90
medulla oblongata, newborn, donor10223	10361-105F1	77.42	25.34	15.97	3.12	7.29	1.04	1.39
medulloblastoma cell line:D283 Med	10838-111E1	40.96	24.13	13.95	17.05	4.87	5.98	1.33
medulloblastoma cell line:ONS-76	10759-110E3	21.15	25.80	4.77	1.83	7.46	1.96	0.37
melanoma cell line:COLO 679	10514-107E1	47.01	7.62	6.47	5.32	1.29	2.16	1.15
melanoma cell line:G-361	10465-106H6	46.69	14.39	5.16	3.80	3.80	2.17	0.54
meningioma cell line:HKBMM	10691-109F7	51.20	23.52	4.88	4.16	4.34	0.90	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	155.96	48.46	37.89	14.10	4.41	15.86	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	111.73	42.51	31.63	11.92	9.85	9.85	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	49.56	46.49	13.50	4.30	7.67	3.68	3.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	49.81	13.09	4.54	2.54	2.91	0.91	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	41.00	40.17	7.04	2.90	4.97	2.48	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.61	12.92	5.06	1.26	2.39	0.84	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	43.33	18.87	7.70	3.66	2.50	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.87	20.13	9.72	2.78	4.16	2.08	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	53.72	17.51	8.24	0.69	3.78	1.20	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	32.89	16.45	5.41	3.22	1.96	1.27	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.42	34.09	10.74	1.46	4.77	2.65	2.39
mesenchymal precursor cell - cardiac, donor4	11755-123G9	45.24	27.14	9.86	2.43	4.73	2.30	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.44	20.91	7.11	1.99	2.85	2.13	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	45.45	17.79	4.28	3.95	2.63	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	41.79	24.91	9.69	2.49	2.77	1.80	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	46.43	28.62	8.73	3.49	6.28	3.14	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	40.02	23.89	9.39	1.84	4.90	1.63	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	37.02	16.18	5.39	1.44	2.16	2.88	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.93	13.45	4.86	1.76	2.38	0.93	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	29.87	15.96	5.24	1.82	4.10	5.93	2.05
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	73.42	36.08	13.85	4.62	5.87	2.94	3.78
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	29.89	22.71	7.77	1.05	3.14	1.49	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	39.65	16.19	6.91	1.84	1.93	1.58	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.77	8.84	5.15	1.10	2.58	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	42.92	14.88	4.58	2.86	2.00	3.72	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	62.31	59.36	21.05	5.89	14.74	10.95	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	50.23	22.38	11.42	1.83	3.20	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	46.55	23.79	13.05	1.79	7.16	2.05	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	43.19	22.77	8.38	2.62	3.93	1.05	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	43.75	20.33	6.16	1.54	4.62	1.54	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.72	23.54	11.53	2.82	5.41	1.18	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	47.05	21.66	8.80	2.37	5.42	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	43.62	24.76	7.86	1.57	3.14	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	56.53	20.85	7.88	1.85	5.10	1.85	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	62.87	28.84	14.13	1.73	7.50	0.87	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	41.50	20.08	7.14	1.78	5.13	1.78	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	45.67	20.67	9.13	2.88	5.77	2.64	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	44.73	30.80	11.73	1.47	2.93	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	50.35	21.15	10.07	1.01	4.70	1.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	46.26	27.02	10.23	3.28	3.68	1.23	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	50.26	24.91	14.60	3.87	8.16	3.01	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	54.69	24.61	19.14	2.73	5.47	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	25.82	20.66	5.16	5.16	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	58.14	28.58	16.56	3.25	8.77	2.60	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	49.47	23.28	20.37	4.36	4.36	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	65.57	27.72	18.12	3.20	3.73	3.20	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	60.52	22.08	14.72	3.27	2.45	3.27	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	56.75	24.88	13.22	5.83	4.66	2.33	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	50.37	25.18	14.69	4.20	6.30	2.10	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	52.65	30.80	14.90	1.99	6.95	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	23.84	14.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	64.04	40.91	13.05	5.93	5.93	1.19	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	60.92	19.50	10.97	2.44	7.31	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	58.90	30.40	20.90	3.80	6.97	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	60.01	17.94	18.28	1.38	4.83	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	19.34	19.34	4.30	6.45	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	7.98	23.95	7.98	3.99	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	24.11	3.44	0.00	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	61.94	13.45	9.37	2.85	3.26	2.04	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	63.56	17.48	11.12	3.97	3.97	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	58.95	10.02	7.66	2.36	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	67.95	10.60	8.10	4.68	2.81	0.94	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	69.51	9.36	1.34	4.01	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	63.86	10.64	7.10	4.73	3.55	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	56.50	10.27	12.84	2.57	2.57	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	59.89	11.70	4.13	4.82	0.69	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	51.46	12.86	8.91	5.94	3.96	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	41.50	8.97	10.09	3.36	2.24	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.16	19.72	7.63	3.18	1.27	3.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	55.61	24.18	6.04	2.01	6.04	1.21	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	54.51	23.99	8.72	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	68.42	32.94	5.07	1.27	6.34	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	39.45	9.10	9.10	1.21	1.21	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	27.11	9.04	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	50.24	12.36	6.59	3.29	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	52.19	8.33	6.15	2.58	2.78	0.79	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	56.14	15.58	7.14	1.62	1.62	1.95	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	46.86	13.24	4.07	1.02	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.17	7.74	3.09	0.77	2.32	3.09	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	39.45	19.84	7.32	6.38	9.45	0.94	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	43.09	10.19	8.11	4.87	0.93	4.63	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	12.82	4.27	4.27	0.00	8.55	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	78.19	39.35	20.34	3.19	5.96	20.45	9.25
mesothelioma cell line:Mero-25	10850-111F4	65.36	23.83	3.86	9.99	3.18	2.72	1.36
mesothelioma cell line:Mero-41	10851-111F5	48.90	31.54	7.09	8.07	8.56	1.71	0.98
mesothelioma cell line:Mero-48a	10852-111F6	27.68	18.60	6.42	4.21	3.76	2.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	50.98	12.88	12.09	7.62	1.05	3.94	2.37
mesothelioma cell line:Mero-83	10854-111F8	19.23	11.75	4.77	4.60	1.87	4.77	2.04
mesothelioma cell line:Mero-84	10855-111F9	36.15	10.87	8.85	1.77	2.78	6.07	1.52
mesothelioma cell line:Mero-95	10856-111G1	38.51	10.15	7.45	3.52	0.83	1.45	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	19.55	11.10	4.80	4.14	3.31	1.66	1.16
mesothelioma cell line:NCI-H226	10846-111E9	66.60	23.17	13.57	9.05	6.15	7.60	4.52
mesothelioma cell line:NCI-H2452	10848-111F2	59.96	17.94	5.12	5.47	4.10	2.39	0.68
mesothelioma cell line:NCI-H28	10845-111E8	29.77	36.13	5.60	7.89	9.42	4.07	1.27
mesothelioma cell line:No36	10857-111G2	29.68	25.77	8.16	7.83	8.81	2.61	1.96
mesothelioma cell line:ONE58	10858-111G3	20.32	14.36	4.34	4.06	1.90	1.90	0.27
migratory langerhans cells, donor1	11901-125F2	26.10	14.59	4.61	3.07	4.22	1.15	0.19
migratory langerhans cells, donor2	11902-125F3	18.68	11.48	1.83	2.69	3.18	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	33.02	13.28	7.00	2.69	3.77	1.08	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	66.93	16.32	2.94	8.81	3.26	0.98	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.46	44.51	77.14	4.03	8.69	10.38	2.97
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	32.02	16.36	4.38	2.76	2.76	2.30	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	29.88	13.32	7.80	3.23	3.23	3.43	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	71.70	7.39	10.90	11.46	1.85	1.66	0.74
myeloma cell line:PCM6	10474-106I6	124.73	8.10	8.10	7.12	1.19	1.78	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	25.36	26.89	13.70	3.04	5.58	10.15	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	28.83	28.83	6.86	6.67	7.26	1.37	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	47.91	17.05	2.12	7.13	4.12	0.56	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	49.71	24.93	4.34	6.77	6.47	1.03	0.51
nasal epithelial cells, donor2	12227-129F4	20.98	7.73	4.97	4.97	2.21	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	140.11	14.49	18.17	12.19	1.84	2.76	0.23
neuroblastoma cell line:NB-1	10539-107G8	124.22	48.83	37.23	6.55	9.17	3.93	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	49.98	41.55	9.49	19.82	7.17	2.11	0.42
neuroblastoma cell line:NH-12	10555-107I6	131.00	18.64	13.98	9.13	3.91	3.35	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	58.83	10.91	17.55	4.51	0.95	2.14	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	132.41	32.63	17.26	16.15	4.43	1.90	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	74.67	13.28	10.87	6.44	3.42	2.82	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.79	21.62	6.36	4.45	3.18	2.54	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	33.54	15.70	5.32	2.66	2.93	2.93	1.06
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	18.94	18.94	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	35.52	4.06	7.44	9.81	1.01	1.52	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	162.50	170.51	91.26	8.01	34.42	8.81	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	48.41	18.27	12.50	7.37	1.92	1.92	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	43.09	22.07	9.46	3.42	6.31	3.15	1.84
nucleus accumbens, adult, pool1	10037-101F1	29.62	19.31	15.00	0.84	6.37	2.16	0.66
occipital cortex - adult, donor10196	10172-103C1	32.97	32.97	53.57	2.06	2.06	8.24	4.12
occipital cortex, adult, donor10252	10163-103B1	59.58	29.79	23.35	5.64	2.95	1.88	1.34
occipital cortex, newborn, donor10223	10355-105E4	77.52	26.57	46.22	4.00	8.73	4.37	1.46
occipital lobe, adult, donor1	10076-102A4	61.93	29.91	53.79	0.79	12.86	0.79	1.05
occipital lobe, fetal, donor1	10073-102A1	121.01	17.16	51.92	0.86	3.00	2.57	0.00
occipital pole, adult, pool1	10036-101E9	22.55	11.35	13.56	0.87	3.31	0.87	0.47
olfactory region, adult	10195-103E6	57.51	32.29	36.49	1.91	9.36	4.20	2.48
optic nerve, donor1	10277-104E7	24.01	12.01	14.01	4.00	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	30.30	5.58	2.62	2.16	1.94	1.25	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	20.61	14.70	5.08	4.67	1.79	1.65	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	43.52	13.88	9.82	3.05	2.37	4.40	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	59.60	19.41	9.24	5.31	4.50	4.85	1.73
osteoclastoma cell line:Hs 706.T	10704-109H2	23.22	11.76	4.12	1.47	5.00	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	73.81	23.36	8.41	2.80	6.54	7.47	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	53.86	9.97	5.73	5.30	0.85	1.70	0.42
ovary, adult, pool1	10020-101D2	88.31	7.69	2.53	2.10	1.75	0.61	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	44.18	30.61	9.72	9.17	3.85	4.40	1.10
pancreas, adult, donor1	10049-101G4	63.02	12.23	13.17	3.76	3.76	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	72.96	11.18	4.19	6.43	1.96	1.12	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	24.19	14.14	4.60	3.24	4.26	2.21	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	36.59	5.63	1.49	3.81	0.83	0.99	0.17
paracentral gyrus, adult, pool1	10035-101E8	26.82	18.30	17.85	1.46	5.31	2.65	0.46
parietal cortex, adult, donor10258	10373-105G4	7.34	35.97	14.68	0.00	6.61	4.40	1.47
parietal lobe - adult, donor10196	10171-103B9	35.74	38.56	27.27	1.88	10.35	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	45.61	29.93	36.77	1.71	6.27	2.28	2.28
parietal lobe, adult, pool1	10034-101E7	31.37	15.42	16.13	1.67	4.67	1.06	0.53
parietal lobe, fetal, donor1	10072-101I9	104.74	24.25	19.40	3.88	3.88	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	79.63	35.89	40.00	2.24	11.96	4.49	1.87
parotid gland, adult	10199-103F1	41.32	15.42	4.32	0.00	1.23	0.62	0.00
penis, adult	10200-103F2	38.67	24.17	9.67	4.83	4.83	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	68.42	15.43	8.00	10.41	5.02	2.97	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	36.72	10.78	6.41	3.93	2.33	2.04	1.46
pineal gland - adult, donor10196	10179-103C8	38.06	30.96	25.16	0.65	4.52	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	58.04	27.83	17.77	1.18	2.37	4.15	0.59
pineal gland, adult, donor10258	10377-105G8	43.27	52.67	20.69	1.25	18.19	3.14	1.88
pituitary gland - adult, donor10196	10180-103C9	139.63	34.40	20.24	5.06	3.04	1.01	4.05
pituitary gland, adult, donor10252	10162-103A9	137.07	24.50	17.72	6.25	8.86	2.61	0.52
pituitary gland, adult, donor10258	10378-105G9	168.55	58.74	24.69	2.55	11.92	8.51	0.85
placenta, adult, pool1	10021-101D3	40.21	10.11	5.27	1.51	2.37	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	29.66	25.56	8.21	5.30	4.90	5.83	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.50	9.96	7.32	3.74	1.71	0.16	0.31
pons, adult, pool1	10033-101E6	26.85	16.61	12.48	0.77	4.22	1.03	0.43
postcentral gyrus, adult, pool1	10032-101E5	42.28	22.23	26.68	1.39	6.28	1.83	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	4.18	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	99.14	22.03	27.54	5.51	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	73.27	21.85	12.53	7.14	4.52	5.24	1.89
prostate cancer cell line:PC-3	10439-106E7	90.21	35.21	9.26	3.09	6.17	2.90	0.18
prostate, adult, pool1	10022-101D4	40.09	10.88	5.08	1.00	1.90	0.27	0.09
putamen, adult, donor10196	10176-103C5	78.14	48.87	39.89	3.30	17.47	1.89	5.43
putamen, adult, donor10252	10152-102I8	103.92	62.74	37.25	1.96	7.84	3.92	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	15.30	37.16	14.21	5.46	7.65	4.37	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	37.69	23.92	17.40	0.24	7.01	1.21	1.93
putamen, newborn, donor10223	10365-105F5	164.18	41.23	42.73	3.00	16.49	7.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	81.46	8.15	2.91	4.95	1.45	1.16	0.00
rectum, fetal, donor1	10067-101I4	84.85	16.69	31.99	6.95	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	34.56	32.86	5.30	1.70	8.48	2.54	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	37.69	30.24	3.31	9.53	5.80	0.41	0.00
retina, adult, pool1	10030-101E3	21.77	11.83	7.55	1.49	3.48	0.99	0.20
retinoblastoma cell line:Y79	10475-106I7	116.91	37.41	17.15	12.99	7.27	3.90	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.31	15.74	9.96	4.43	2.34	3.20	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	96.73	26.15	15.75	20.53	5.06	2.81	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	36.38	18.19	3.79	0.76	2.27	0.76	0.76
salivary acinar cells, donor1	11771-123I7	28.65	7.93	4.37	1.29	2.10	1.29	0.97
salivary acinar cells, donor2	11772-123I8	24.37	7.30	4.54	2.89	0.83	0.55	0.83
salivary acinar cells, donor3	11773-123I9	25.16	5.96	2.65	3.31	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	14.30	8.01	5.72	7.44	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	32.38	8.60	2.70	1.69	2.19	0.08	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.90	11.28	3.41	1.76	2.59	0.71	0.24
seminal vesicle, adult	10201-103F3	48.15	23.81	13.76	6.35	2.12	3.17	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	66.56	21.62	13.36	7.53	4.62	8.02	4.86
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.63	6.29	5.28	0.75	2.01	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	67.24	40.14	15.05	5.02	14.05	6.02	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	74.14	9.00	12.22	13.97	2.15	4.43	1.34
signet ring carcinoma cell line:Kato III	10436-106E4	27.52	10.94	3.43	3.87	2.65	1.55	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	49.93	20.13	8.64	11.10	2.97	4.77	2.32
skeletal muscle - soleus muscle, donor1	10282-104F3	37.59	73.06	17.02	5.67	17.73	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	72.08	32.62	12.71	0.48	10.31	1.44	0.72
skeletal muscle, fetal, donor1	10066-101I3	112.56	9.05	5.03	0.00	2.01	1.01	0.00
skin, adult, donor1	10074-102A2	54.28	6.79	13.57	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	68.80	11.99	12.62	5.68	5.68	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	68.37	29.68	35.02	10.67	4.34	8.67	4.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	47.28	21.75	25.53	7.25	2.52	5.67	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	109.10	25.06	21.01	10.41	7.32	4.24	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	38.40	20.44	11.37	8.24	2.47	5.27	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	35.39	64.98	4.18	10.94	15.76	0.48	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	58.18	23.10	23.75	7.19	5.23	7.63	1.09
small intestine, adult, pool1	10024-101D6	45.39	9.79	5.73	3.58	1.31	0.60	0.00
small intestine, fetal, donor1	10064-101I1	95.58	10.07	11.06	2.46	3.44	0.49	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	90.27	25.13	20.52	10.77	7.18	9.23	2.56
smooth muscle, adult, pool1	10048-101G3	34.12	9.30	9.82	1.81	4.14	0.78	0.78
somatostatinoma cell line:QGP-1	10781-110G7	56.82	35.65	11.79	5.36	6.43	5.36	0.54
spinal cord - adult, donor10196	10181-103D1	57.81	30.28	22.02	1.15	5.96	0.92	2.06
spinal cord, adult, donor10252	10159-103A6	22.08	13.80	11.04	4.34	2.76	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	16.60	72.64	9.69	2.77	8.30	3.46	6.23
spinal cord, fetal, donor1	10056-101H2	60.98	26.83	31.71	1.83	8.54	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	78.07	49.59	14.24	1.38	11.48	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.49	18.52	5.53	1.79	5.08	0.90	0.30
spleen, adult, pool1	10025-101D7	36.78	5.29	2.86	1.21	0.77	0.55	0.22
spleen, fetal, pool1	10044-101F8	25.03	3.81	3.26	2.78	0.87	0.40	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	65.42	14.60	7.87	6.62	3.42	3.62	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	40.82	9.30	6.08	7.03	1.33	3.42	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	53.82	25.16	22.71	5.94	3.49	9.78	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	104.38	20.33	6.65	3.91	3.13	6.65	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	157.47	31.07	15.42	6.87	8.89	5.40	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	110.98	38.12	21.18	7.62	3.39	11.01	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	37.23	11.85	7.19	0.85	2.96	4.23	1.27
stomach, fetal, donor1	10062-101H8	60.87	18.16	13.88	8.54	6.41	2.14	0.00
submaxillary gland, adult	10202-103F4	52.41	10.25	2.85	5.70	2.85	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	54.27	162.82	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	37.59	29.49	13.71	4.98	7.89	2.08	1.87
substantia nigra, adult, donor10258	10371-105G2	6.72	43.97	10.35	1.55	8.28	3.10	1.03
substantia nigra, newborn, donor10223	10358-105E7	69.95	19.78	19.78	1.41	8.48	2.83	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	110.51	33.70	22.47	11.00	6.65	7.57	0.69
temporal lobe, adult, pool1	10031-101E4	36.11	20.77	21.70	0.68	6.95	1.44	1.02
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	128.92	9.26	24.22	4.27	2.14	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	83.51	13.19	13.63	2.20	5.71	0.88	1.76
tenocyte, donor1	11763-123H8	28.98	18.85	8.73	4.54	2.09	1.05	0.35
tenocyte, donor2	11765-123I1	42.73	14.12	9.16	3.43	4.96	0.76	0.00
tenocyte, donor3	11768-123I4	33.36	30.77	10.75	5.93	4.82	3.71	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	49.12	31.61	10.20	8.16	5.95	4.76	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	65.05	35.45	22.81	20.96	8.48	8.63	2.47
teratocarcinoma cell line:PA-1	10807-111A6	28.52	26.19	13.33	5.27	2.79	2.63	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	64.24	37.83	21.33	11.43	5.33	9.14	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	71.47	30.25	8.70	5.67	3.78	1.89	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	72.09	19.52	4.58	7.85	1.31	0.87	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	62.53	23.78	14.33	8.14	8.14	2.93	0.33
testis, adult, pool1	10026-101D8	46.38	14.39	9.02	0.97	8.27	0.64	0.00
testis, adult, pool2	10096-102C6	18.95	29.77	4.96	2.71	22.10	0.90	0.00
thalamus - adult, donor10196	10168-103B6	25.39	29.81	32.02	1.10	4.42	0.00	1.10
thalamus, adult, donor10252	10154-103A1	36.41	29.38	11.56	3.75	5.94	1.56	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	36.95	10.78	3.08	1.54	6.16	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	39.69	35.74	19.10	1.15	5.93	2.31	1.81
thalamus, newborn, donor10223	10366-105F6	82.27	42.57	51.20	0.00	10.93	5.18	2.30
throat, adult	10209-103G2	37.95	19.97	14.23	4.49	4.24	1.25	0.75
throat, fetal, donor1	10061-101H7	63.68	17.37	15.84	3.05	1.83	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	153.62	29.41	32.79	11.92	2.58	7.95	1.59
thymus, adult, pool1	10027-101D9	47.42	6.36	6.46	0.70	2.19	0.60	0.20
thymus, fetal, pool1	10043-101F7	40.83	6.23	3.64	4.88	1.45	0.21	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	54.38	31.25	11.70	4.39	5.32	4.92	3.06
thyroid carcinoma cell line:TCO-1	10783-110G9	32.13	26.54	9.50	6.98	9.22	3.77	0.84
thyroid, adult, pool1	10028-101E1	67.84	14.09	10.08	1.12	2.43	0.65	0.37
thyroid, fetal, donor1	10060-101H6	42.45	15.56	12.92	3.95	3.16	1.85	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	9.24	12.32	6.16	3.08	0.00	0.00
tongue, adult	10203-103F5	46.28	23.03	15.12	4.88	7.68	3.95	0.00
tongue, fetal, donor1	10059-101H5	61.87	28.37	17.73	1.58	7.49	0.79	0.79
tonsil, adult, pool1	10047-101G2	39.17	7.61	6.31	4.31	2.10	0.50	0.10
trachea, adult, pool1	10029-101E2	34.68	9.41	4.91	2.04	1.96	0.49	0.49
trachea, fetal, donor1	10058-101H4	94.25	11.16	12.69	3.46	1.92	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.24	28.70	8.50	4.25	6.02	2.83	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	37.49	6.18	5.67	2.23	0.81	2.13	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	129.27	22.88	9.71	9.87	4.86	3.45	1.41
tridermal teratoma cell line:HGRT	10694-109G1	51.37	45.66	1.90	1.90	3.81	3.81	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	59.68	19.47	9.40	6.18	3.64	5.42	1.95
umbilical cord, fetal, donor1	10057-101H3	41.73	20.87	22.95	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	14.33	9.73	5.63	2.56	1.88	0.51	0.00
uterus, fetal, donor1	10055-101H1	107.50	10.75	11.77	0.51	2.05	0.00	0.00
vagina, adult	10204-103F6	59.45	9.69	3.23	0.65	1.29	0.00	0.00
vein, adult	10191-103E2	46.25	8.11	6.80	2.85	2.41	0.88	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	52.34	16.29	7.48	6.41	4.27	1.87	1.07